C. Cameron Yin, M.D., Ph.D.

Peer-Reviewed Articles

1. Nirmalanantham P, Quesada AE, Ghosh A, Lin P, Ok CY, Yang RK, Fang H, Garces S, Kanagal-Shamanna R, Loghavi S, Routbort MJ, Yin CC, Wei W, Pasyar S, Bassett R, El Hussein S, Jain N, Burger J, Wierda WG, Wang S, Bueso-Ramos C, Patel KP, Medeiros LJ, Jelloul FZ. Mutational Landscape and Clinical Impact of SPEN Mutations in Patients with Chronic Lymphocytic Leukemia. Cancers (Basel) 17(21), 2025. e-Pub 2025. PMID: 41228377.
2. Ok CY, Tang G, Loghavi S, Hu S, Wei Q, Quesada AE, Routbort MJ, Kanagal-Shamanna R, Yin CC, Sarami I, Garces S, Agarwal NK, Luthra R, Fang H, Jelloul FZ, Bryan J, Medeiros LJ, Patel KP, Toruner GA. Comparative Analysis of Targeted RNA-Seq and Optical Genome Mapping for Detecting Gene Rearrangements in Acute Leukemia. Cancers (Basel) 17(21), 2025. e-Pub 2025. PMID: 41228256.
3. E S, Medeiros LJ, Fang H, Li S, Tang G, Wang SA, Wang W, Yin CC, You MJ, Iyer SP, Malpica L, Qiu L, Tang Z, Wei Q, Lin P, Xu J. Low CD25 in ALK+ Anaplastic Large Cell Lymphoma Is Associated with Older Age, Thrombocytopenia, and Increased Expression of Surface CD3 and CD8. Cancers (Basel) 17(11), 2025. e-Pub 2025. PMID: 40507248.
4. Kim DH, Medeiros LJ, Xu J, Tang G, Qiu L, Wang SA, Ok CY, Wang W, Yin CC, You MJ, Garces S, Lin P, Li S. Diffuse Large B-Cell Lymphoma/High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Study of 60 Cases. Mod Pathol 38(5):100710, 2025. e-Pub 2025. PMID: 39805522.
5. Hong J, Sui P, Li Y, Xu KY, Lee JH, Wang J, Chen S, Zhang P, Wingate N, Noor A, Yuan Y, Hromas R, Zhou H, Hamamoto K, Su R, Yin CC, Ye F, Quesada AE, Chen J, Huang S, Zhou D, You MJ, Yang FC, Wang J, Xu M. PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1. Cell Stem Cell 32(3):463-478.e6, 2025. e-Pub 2025. PMID: 39954676.
6. E S, Xu J, Wang SA, Tang G, Jabbour EJ, Li S, You MJ, Medeiros LJ, Yin CC. Blast phase of chronic myeloid leukemia presenting as early T-cell precursor acute lymphoblastic leukemia. Am J Clin Pathol, 2024. e-Pub 2024. PMID: 39235991.
7. Yan H, Wu L, Wang P, Xia M, Shi Z, Huang X, Yin S, Jiang Q, Yin CC*, Zhao X*, Qiu X* (*Contributed equally as co-corresponding authors). A Comparative Analysis of the Immunoglobulin Repertoire in Leukemia Cells and B Cells in Chinese Acute Myeloid Leukemia by High-Throughput Sequencing. Biology (Basel) 13(8), 2024. e-Pub 2024. PMID: 39194551.
8. Yan, H, Wu, L, Wang, P, Xia, M, Shi, Z, Huang, X, Yin, S, Jiang, Q, Yin, CC, Zhao, X, Qiu, X. A Comparative Analysis of the Immunoglobulin Repertoire in Leukemia Cells and B Cells in Chinese Acute Myeloid Leukemia by High-Throughput Sequencing. Biology 13(8), 2024. e-Pub 2024. PMID: 39194551.
9. Fang H, Wang SA, Beird HC, Tang Z, You MJ, Li S, Xu J, Hu S, Yin CC, El Hussein S, Lin P, Jelloul FZ, Vega F, Medeiros LJ, Wang W. Morphology, immunophenotype, and suggested diagnostic criteria of TCL1 family-negative T-prolymphocytic leukemia. Am J Clin Pathol, 2024. e-Pub 2024. PMID: 38946194.
10. Yin CC, Tam W, Walker SM, Kaur A, Ouseph MM, Xie W, K Weinberg O, Li P, Zuo Z, Routbort MJ, Chen S, Medeiros LJ, George TI, Orazi A, Arber DA, Bagg A, Hasserjian RP, Wang SA. STAT5B mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia. Haematologica 109(6):1825-1835, 2024. e-Pub 2024. PMID: 37981812.
11. Shuyu, E, Nahmod, KA, Wang, S, Yin, CC. Unique blast phase of chronic myeloid leukemia with concurrent erythroid and megakaryocytic differentiation. International Journal of Laboratory Hematology 46(1):5-7, 2024. e-Pub 2024. PMID: 37674279.
12. Li, S, Tang, G, Jain, P, Lin, P, Xu, J, Miranda, R, Cheng, J, Yin, CC, You, MJ, Wang, ML, Medeiros, LJ. SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-Cell Lymphoma?. Modern Pathology 37(2), 2024. e-Pub 2024. PMID: 38104893.
13. Hong T, Li J, Guo L, Cavalier M, Wang T, Dou Y, DeLaFuente A, Fang S, Guzman A, Wohlan K, Kapadia C, Rosas C, Yang Y, Yin CC, Li S, You MJ, Cheng X, Goodell MA, Zhou Y, Huang Y. TET2 modulates spatial relocalization of heterochromatin in aged hematopoietic stem and progenitor cells. Nat Aging 3(11):1387-1400, 2023. e-Pub 2023. PMID: 37884767.
14. Fang H, Beird HC, Wang SA, Ibrahim AF, Tang Z, Tang G, You MJ, Hu S, Xu J, Li S, Yin CC, El Hussein S, Le N, Futreal PA, Bueso-Ramos C, Thakral B, Kadia TM, Thornton R, Little L, Gumbs C, Song X, Medeiros LJ, Wang W. T-Prolymphocytic Leukemia: TCL1 or MTCP1 Rearrangement is not Mandatory to Establish Diagnosis. Leukemia 37(9):1919-1921, 2023. e-Pub 2023. PMID: 37443196.
15. Jelloul FZ, Routbort MJ, DiNardo CD, Bueso-Ramos CE, Kanagal-Shamanna R, Thakral B, Zuo Z, Yin CC, Loghavi S, Ok CY, Wang SA, Tang Z, You MJ, Patel KP, Medeiros LJ, AE| Q. DDX41 Mutations in Patients with Non-Myeloid Hematologic Neoplasms. Am J Hematol 98(8):E193-E196, 2023. e-Pub 2023. PMID: 37154083.
16. Li N, Lin P, Zuo Z, You MJ, Shuai W, Orlowski R, Manasanch EE, Li S, Xu J, Garces S, Jelloul FZ, Tang Z, Wang W, Medeiros LJ, Yin CC. Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease and poorer prognosis. Cancer Med 12(13):14293-14304, 2023. e-Pub 2023. PMID: 37212518.
17. Zhu HH, Qin YZ, Zhang ZL, Liu YJ, Wen LJ, You MJ, Zhang C, Such E, Luo H, Yuan HJ, Zhou HS, Liu HX, Xu R, Li J, Li JH, Hao JP, Jin J, Yu L, Zhang JY, Liu LP, Zhang LP, Huang RB, Shen SH, Gao SJ, Wang W, Yan XJ, Zhang XY, Du X, Chu XX, Yu YF, Wang Y, Mi YC, Lu Y, Cai Z, Su Z, Taussig DC, MacMahon S, Ball ED, Wang HY, Welch JS, Yin CC, Borthakur G, Sanz MA, Kantarjian HM, Huang JY, Hu J, Chen SN. A global study for acute myeloid leukemia with RARG rearrangement. Blood Advances 7(13):2972-2982, 2023. e-Pub 2023. PMID: 36799929.
18. Jelloul FZ, Quesada AE, Yang RK, Li S, Wang W, Xu J, Tang G, Yin CC, Fang H, El Hussein S, Khoury J, Bassett RL, Garcia-Manero G, Manasanch EE, Orlowski RZ, Qazilbash MH, Patel KP, Medeiros LJ, Lin P. Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies. Mod Pathol 36(6):100166, 2023. e-Pub 2023. PMID: 36990279.
19. Beird H*, Yin CC*, Khoury JD, Pierce S, Abbas HA, Zhao L, Skwarska A, Qazilbash M, Konopleva M, Futreal PA, Pemmaraju N (*These two authors contributed equally to this work). TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm. Blood Advances 7(10):2000-2003, 2023. e-Pub 2023. PMID: 36689729.
20. Xu J, Li S, Yin CC, Patel KP, Tang G, Wang W, Miranda RN, Garces S, Tang Z, Lin P, Medeiros LJ. Classic Hodgkin Lymphoma with Marked Granulomatous Reaction: A Clinicopathologic Study of 20 Cases. Hum Pathol 134:114-123, 2023. e-Pub 2023. PMID: 36584716.
21. Shuai W, Zuo Z, Li N, Garces S, Jelloul FZ, Ok CY, Li S, Xu J, You MJ, Wang W, Rehder C, Jabbour EJ, Patel KP, Medeiros LJ, Yin CC. ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia. Cancer 129(6):878-889, 2023. e-Pub 2023. PMID: 36583229.
22. Qiu L, Xu J, Lin P, Cohen EN, Tang G, Wang SA, Khanlari M, Wang W, Khoury JD, Konoplev S, Yin CC, Jorgensen JL, Vega F, Medeiros LJ, Li S. Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B acute lymphoblastic leukemia/lymphoma. Haematologica 108(3):895-899, 2023. e-Pub 2023. PMID: 36325892.
23. Qiu L, Wang SA, Tang G, Wang W, Lin P, Xu J, Yin CC, Khanlari M, Medeiros LJ, Li S. Blastoid B-Cell Neoplasms: Diagnostic Challenges and Solutions. Cancers (Basel) 15(3), 2023. e-Pub 2023. PMID: 36765805.
24. Tang Z, Wang W, Yang S, El Achi H, Fang H, Nahmod KA, Toruner GA, Xu J, Thakral B, Ayoub E, Issa GC, Yin CC, You MJ, Miranda RN, Khoury JD, Medeiros LJ, Tang G. 3q26.2/MECOM Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features. Cancers (Basel) 15(2), 2023. e-Pub 2023. PMID: 36672407.
25. Lyu J, Liu Y, Gong L, Chen M, Madanat YF, Zhang Y, Cai F, Gu Z, Cao H, Kaphle P, Kim YJ, Kalkan FN, Stephens H, Dickerson KE, Ni M, Chen W, Patel P, Mims AS, Borate U, Burd A, Cai SF, Yin CC, You MJ, Chung SS, Collins RH, DeBerardinis RJ, Liu X, Xu J. Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance. Cancer Discov 13(1):170-193, 2023. e-Pub 2023. PMID: 36222845.
26. Zuo Z, Medeiros LJ, Yin CC. Acute myeloid leukemia with concurrent NPM1 and RUNX1 mutations. Leuk Res Rep 20:100385, 2023. e-Pub 2023. PMID: 37680325.
27. Zuo Z, Medeiros LJ, Garces S, Routbort MJ, Ok CY, Loghavi S, Kanagal-Shamanna R, Jelloul FZ, Garcia-Manero G, Chien KS, Patel KP, Luthra R, Yin CC. Concurrent Mutations in SF3B1 and PHF6 in Myeloid Neoplasms. Biology (Basel) 12(1), 2022. e-Pub 2022. PMID: 36671709.
28. Wang Y, Quesada AE, Zuo Z, Medeiros LJ, Yin CC, Li S, Xu J, Borthakur G, Li Y, Yang C, Abaza Y, Gao J, Lu X, You MJ, Zhang Y, Lin P. The Impact of Mutation of Myelodysplasia-Related Genes in De Novo Acute Myeloid Leukemia Carrying NPM1 Mutation. Cancers (Basel) 15(1), 2022. e-Pub 2022. PMID: 36612194.
29. Garces S, Rudzki Z, Yin CC, Miranda RN, Medina AM, Sriganeshan V, Cuglievan B, Li S, Xu J, Jelloul F, Khoury JD, Thakral B, Tang G, Garces JC, Medeiros LJ. MUM1/IRF4 is Highly Expressed in Dermatopathic Lymphadenopathy: Potential Utility in Diagnosis and Differential Diagnosis. Am J Surg Pathol 46(11):1514-1523, 2022. e-Pub 2022. PMID: 35877199.
30. Wang W, Xu J, Khoury JD, Pemmaraju N, Fang H, Miranda RN, Yin CC, Hussein SE, Jia F, Tang Z, Hu S, Konopleva M, Medeiros LJ, Wang SA. Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation are distinct From Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers (Basel) 14(14), 2022. e-Pub 2022. PMID: 35884435.
31. Fang H, Wang SA, Hu S, Konoplev SN, Mo H, Liu W, Zuo Z, Xu J, Jorgensen JL, Yin CC, El Hussein S, Jelloul FZ, Tang Z, Medeiros LJ, Wang W. Acute Promyelocytic Leukemia: Immunophenotype and Differential Diagnosis by Flow Cytometry. Cytometry B Clin Cytom 102(4):283-291, 2022. e-Pub 2022. PMID: 35716019.
32. Wang L, Wang W, Beird HC, Cheng X, Fang H, Tang G, Toruner GA, Yin CC, You MJ, Issa GC, Borthakur G, Peng G, Khoury JD, Medeiros LJ, Tang Z. PPP1R7 is a novel translocation partner of CBFB via t(2;16)q37;q22) in Acute Myeloid Leukemia. Genes (Basel) 13(8), 2022. e-Pub 2022. PMID: 36011278.
33. Khanlari M, Yin CC, Takahashi K, Lachowiez C, Tang G, Loghavi S, Bah I, Wang W, Konoplev S, Medeiros LJ, Pemmaraju N, Khoury JD, Wang SA. Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients. Leukemia 36(5):1343-1350, 2022. e-Pub 2022. PMID: 35279700.
34. Jelloul FZ, Yang R, Garces S, Kanagal-Shamanna R, Ok CY, Loghavi S, Routbort MJ, Zuo Z, Yin CC, Floyd K, Bassett RL, Wierda W, Jain N, Thompson P, Luthra R, Medeiros LJ, Patel KP. Landscape of NOTCH1 Mutations and Co-occurring Biomarker Alterations in Chronic Lymphocytic Leukemia. Leuk Res 116:106827, 2022. e-Pub 2022. PMID: 35430388.
35. Manshouri T, Veletic I, Li P, Yin CC, Post SM, Verstovsek S, Estrov Z. GLI1 Activates Pro-Fibrotic Pathways in Myelofibrosis Fibrocytes. Cell Death Dis 13(5):481, 2022. e-Pub 2022. PMID: 35595725.
36. Mankar R, Gajjela CC, Bueso-Ramos CE, Yin CC, Mayerich D, Reddy RK. Polarization sensitive photothermal mid-infrared spectroscopic imaging of human bone marrow tissue. Appl Spectrosc 76(4):508-518, 2022. e-Pub 2022. PMID: 35236126.
37. Zhao M, Medeiros LJ, Wang W, Tang G, Jung HS, Sfamenos SM, Fang H, Toruner GA, Hu S, Yin CC, Lin P, Gu J, Peng G, You MJ, Khoury JD, Wang SA, Tang Z. Newly Designed Breakapart FISH Probe Helps to Identify Cases with True MECOM Rearrangement in Myeloid Malignancies. Cancer Genet 262-263:23-29, 2022. e-Pub 2022. PMID: 34974290.
38. Jelloul FZ, Yang RK, Wang P, Garces S, Kanagal-Shamanna R, Ok CY, Loghavi S, Routbort MJ, Zuo Z, Yin CC, Floyd K, Bassett RL, Wierda WG, Jain N, Thompson PA, Luthra R, Medeiros LJ, Patel KP. Non-coding NOTCH1 mutations in chronic lymphocytic leukemia negatively impact prognosis. Am J Hematol 97(3):E100-E102, 2022. e-Pub 2022. PMID: 34989420.
39. Khanlari M, Li S, Miranda RN, Iyer S, Konoplev S, Lin P, Yin CC, Tang G, Qiu L, Vega F, Medeiros LJ, Xu J. Small cell/lymphohistiocytic morphology is associated with peripheral blood involvement, CD8 positivity and retained T cell antigens, but not outcome in adults with ALK+ anaplastic large cell lymphoma. Mod Pathol 35(3):412-418, 2022. e-Pub 2022. PMID: 34628481.
40. Garces S, Medeiros LJ, Marques-Piubelli ML, Coelho Siqueira SA, Miranda RN, Cuglievan B, Sriganeshan V, Medina AM, Garces JC, Saluja K, Bhattacharjee MB, Khoury JD, Li S, Xu J, Jelloul FZ, Thakral B, Yin CC. Cyclin D1 expression in Rosai-Dorfman disease: a near-constant finding that is not invariably associated with mitogen-activated protein kinase/extracellular signal-regulated kinase pathway activation (Image selected as the cover page by the journal). Hum Pathol 121:36-45, 2022. e-Pub 2022. PMID: 34995673.
41. Wang ML, Jain P, Zhao S, Lee HJ, Nastoupil L, Fayad L, Ok CY, Kanagal-Shamanna R, Hill HA, Yao Y, Hagemeister FB, Westin JR, Fowler N, Samaniego F, Steiner R, Nair R, Iyer SP, Navsaria L, Badillo M, Research Group MC, Feng L, Xuelin H, Nogueras Gonzalez GM, Xu G, Wagner-Bartak N, Thirumurthi S, Santos D, Tang G, Lin P, Wang SA, Jorgensen J, Yin CC, Li S, Patel KP, Vega F, Medeiros LJ, Flowers CR, Wang L. Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (=65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial. Lancet Oncol 23(3):406-415, 2022. e-Pub 2022. PMID: 35074072.
42. Khanlari M, Medeiros LJ, Lin P, Xu J, You MJ, Tang G, Yin CC, Wang W, Qiu L, Miranda RN, Bueso-Ramos CE, Li S. Blastoid High Grade B-cell Lymphoma Initially Presenting in Bone Marrow: A Diagnostic Challenge,. Mod Pathol 35(3):419-426, 2022. e-Pub 2022. PMID: 34608246.
43. Khanlari M, Wang X, Loghavi S, Wang SA, Li S, Thakral B, Bueso-Ramos CE, Yin CC, Kanagal-Shamanna R, Khoury JD, Patel KP, Popat UR, Medeiros LJ, Konoplev S. Value and Pitfalls of Assessing Bone Marrow Morphologic Findings to Predict Response in Patients with Myelofibrosis Who Undergo Hematopoietic Stem Cell Transplantation. Ann Diagn Pathol 56:151860, 2022. e-Pub 2022. PMID: 34823075.
44. Li S, Xu J, Yin CC, Konoplev S. Richter Transformation with Marked Plasmacytic Differentiation, Mimicking Plasma Cell Neoplasm. EJHaem 3(1):241-242, 2022. e-Pub 2022. PMID: 35846217.
45. Xia M, Wu L, Sun X, Han X, Yan H, Huang J, Zhang Y, Hu Z, Zu Y, Yin CC*, Qiu X* (*Contributed equally as co-corresponding authors). Next-Generation Sequencing Revealed a Distinct Immunoglobulin Repertoire with Specific Mutation Hotspots in Acute Myeloid Leukemia. Biology (Basel) 11(2), 2022. e-Pub 2022. PMID: 35205028.
46. Qiu L, Xu J, Tang G, Wang SA, Lin P, Ok CY, Garces S, Yin CC, Khanlari M, Vega F, Medeiros LJ, Li S. Mantle Cell Lymphoma with Chronic Lymphocytic Leukemia-Like Features: A Diagnostic Mimic and Pitfall. Hum Pathol 119:59-68, 2022. e-Pub 2022. PMID: 34767860.
47. Yu F, He H, Nastoupil LJ, Xu-Monette ZY, Pham K, Liang Y, Chen G, Fowler NH, Yin CC, Tan D, Yang Y, Hu S, Young KH, Pham LV, You MJ. Targetable vulnerability of deregulated FOXM1/PLK1 signaling axis in diffuse large B cell lymphoma. Am J Cancer Res 12(10):4666-4679, 2022. e-Pub 2022. PMID: 36381323.
48. Richard-Carpentier G, Kantarjian HM, Tang G, Yin CC, Khoury JD, Issa GC, Haddad FG, Jain N, Ravandi F, Short NJ, DiNardo CD, Takahashi K, Konopleva MY, Daver NG, Kadia TM, Garcia-Manero G, Garris R, O'Brien SM, Jabbour EJ. Outcomes of Acute Lymphoblastic Leukemia with KMT2A (MLL) rearrangement - The MD Anderson Experience. Blood Adv 5(23):5415-5419, 2021. e-Pub 2021. PMID: 34525185.
49. Qiu L, Medeiros LJ, Tang G, Khanlari M, Li S, Konoplev S, Wang SA, Yin CC, Khoury JD, Wang W, Miranda RN, Iyer S, You MJ, Xu J. The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype, TP53 Deletion, and a Poor Prognosis. Cancers (Basel) 13(24), 2021. e-Pub 2021. PMID: 34944936.
50. Yin CC, Pemmaraju N, You MJ, Li S, Xu J, Wang W, Tang Z, Alswailmi O, Bhalla KN, Qazilbash MH, Konopleva M, Khoury JD. Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm (As a recognition of the importance of this work, data from this paper was curated in the COSMIC database.). Cancers (Basel) 13(23), 2021. e-Pub 2021. PMID: 34884997.
51. Yang RK, Toruner GA, Wang W, Fang H, Issa GC, Wang L, Quesada AE, Thakral B, Patel KP, Peng G, Liu S, Yin CC, Borthakur G, Tang Z, Wang SA, Miranda RN, Khoury JD, Medeiros LJ, Tang G. CBFB Break-Apart FISH Testing: An Analysis of 1629 AML Cases with a Focus on Atypical Findings and Their Implications in Clinical Diagnosis and Management. Cancers (Basel) 13(21), 2021. e-Pub 2021. PMID: 34771519.
52. Wang L, Tang G, Medeiros LJ, Xu J, Huang W, Yin CC, Wang M, Jain P, Lin P, Li S. MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma. Haematologica 106(5):1381-1389, 2021. e-Pub 2021. PMID: 32273477.
53. Jain P, Kanagal-Shamanna R, Zhang S, Ok CY, Navsaria L, Nastoupil L, Lee HJ, Tang G, Yin CC, Badillo M, Nair R, Li S, Patel KM, Flowers C, Vega F, Wang L, Wang ML. Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib. Am J Hematol 96(5):E137-E140, 2021. e-Pub 2021. PMID: 33491779.
54. Lyapichev KA, Tang G, Li S, You MJ, Cheng TJ, Miranda RN, Iyer S, Yin CC, Konoplev S, Bueso-Ramos C, Vega F, Medeiros LJ, Xu J. MYC expression is associated with older age, common morphology, increased MYC copy number, and poorer prognosis in patients with ALK+ anaplastic large cell lymphoma. Hum Pathol 108:22-31, 2021. e-Pub 2021. PMID: 33221344.
55. Yilmaz M, Kantarjian HM, Toruner G, Yin CC, Kanagal-Shamanna R, Cortes JE, Issa G, Short NJ, Khoury JD, Garcia-Manero G, Ravandi F, Kadia T, Konopleva M, Wierda WG, Jain N, Estrov Z, Sasaki K, Pierce S, O'Brien SM, Jabbour EJ. Translocation t(1;19)(q23;p13) in adult acute lymphoblastic leukemia - a distinct subtype with favorable prognosis. Leuk Lymphoma 62(1):1-5, 2021. e-Pub 2021. PMID: 32955970.
56. Khanlari M, Tang G, Hao S, Gong Y, Li S, Miranda RN, Lin P, Iyer S, Yin CC, Xie W, Vega F, Medeiros LJ, Xu J. Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement. Br J Haematol 192(1):e17-e21, 2021. e-Pub 2021. PMID: 33216956.
57. Lyapichev KA, Sakhdari A, Khoury JD, O'Malley DP, El Hussein S, Yin CC, Patel KP, Thakral B, Young KH, Medeiros LJ, Konoplev S. Lymphoid Enhancer Binding Factor 1 (LEF1) Expression is Significantly Higher in Hodgkin Lymphoma Associated with Richter Syndrome Relative to de novo Classic Hodgkin Lymphoma. Ann Diagn Pathol 49:151636, 2020. e-Pub 2020. PMID: 32977233.
58. Wu L, Xia M, Sun X, Han X, Zu Y, Jabbour EJ, You MJ, Lin P, Li S, Xu J, Han H, Bueso-Ramos CE, Medeiros LJ, Qiu X, Yin CC. High levels of immunoglobulin expression predict shorter overall survival in patients with acute myeloid leukemia. Eur J Haematol, 2020. e-Pub 2020. PMID: 32535947.
59. Tang Z, Toruner GA, Tang G, Yin CC, Wang W, Hu S, Thakral B, Wang SA, Miranda RN, Khoury JD, Medeiros LJ. Chronic myeloid leukemia with insertion-derived BCR-ABL1 fusion: redefining complex chromosomal abnormalities by correlation of FISH and karyotype predicts prognosis. Mod Pathol 33(10):2088, 2020. e-Pub 2020. PMID: 32737448.
60. Zhao S, Kanagal-Shamanna R, Navsaria L, Ok CY, Zhang S, Nomie K, Han G, Hao D, Hill HA, Jiang C, Yao Y, Nastoupil L, Westin J, Fayad L, Nair R, Steiner R, Ahmed S, Samaniego F, Iyer SP, Oriabure O, Chen W, Song X, Zhang J, Badillo M, Moghrabi O, Aranda J, Tang G, Yin CC, Patel K, Medeiros LJ, Li S, Vega F, Thirumurthi S, Xu G, Neelapu S, Flowers CR, Romaguera J, Fowler N, Wang L, Wang ML, Jain P. Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients. Am J Hematol 95(6):623-629, 2020. e-Pub 2020. PMID: 32239765.
61. Gong Z, Zhou T, Liu H, Tang G, Yin CC, Wang W, Medeiros LJ, Hu S. Genotype-phenotype correlation of unusual BCR-ABL1 transcripts in Philadelphia chromosome-positive leukaemia. Br J Haematol 189(5):e207-e211, 2020. e-Pub 2020. PMID: 32237084.
62. Li N, Ma Y, Wang W, Yin CC, Wu W, Sun R, Zhao G, Li S, Wang X. LOC101928834, a novel lncRNA in Wnt/β-catenin signaling pathway, promotes cell proliferation and predicts poor clinical outcome in myelodysplastic syndromes. Clin Sci (Lond) 134(11):1279-1293, 2020. e-Pub 2020. PMID: 32463458.
63. Garces S, Yin CC, Miranda RN, Patel KP, Li S, Xu J, Thakral B, Poppiti RJ, Medina AM, Sriganeshan V, Castellano-Sánchez A, Khoury JD, Garces JC, Medeiros LJ. Clinical, Histopathologic and Immunoarchitectural Features of Dermatopathic Lymphadenopathy: An Update. Mod Pathol 33(6):1104-1121, 2020. e-Pub 2020. PMID: 31896812.
64. Xu J, Liu JL, Medeiros LJ, Huang W, Khoury JD, McDonnell TJ, Tang G, Schlette E, Yin CC, Bueso-Ramos CE, Lin P, Li S. MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP treated diffuse large B-cell lymphoma. Eur J Haematol 104(4):336-343, 2020. e-Pub 2020. PMID: 31944390.
65. Shen J, Medeiros LJ, Li S, Wang SA, Lin P, Khanlari M, Iyer SP, Yin CC, Tang G, Jorgensen JL, Hu S, Miranda RN, Xu J. CD8 expression in anaplastic large cell lymphoma correlates with noncommon morphologic variants and T-cell antigen expression suggesting biological differences with CD8-negative anaplastic large cell lymphoma. Hum Pathol 98:1-9, 2020. e-Pub 2020. PMID: 32032618.
66. Jain P, Zhang S, Kanagal-Shamanna R, Ok CY, Nomie K, Gonzalez GN, Gonzalez-Pagan O, Hill HA, Lee HJ, Fayad L, Westin J, Nastoupil L, Hagemeister F, Chen W, Oriabure O, Badillo M, Jiang C, Yixin Y, Li S, Tang G, Yin CC, Patel KP, Medeiros LJ, Nair R, Ahmed S, Iyer SP, Thirumurthi S, Champlin R, Xu G, Tinsu P, Santos D, Wang R, Han G, Zhang J, Song X, Neelapu S, Romaguera J, Futreal A, Flowers C, Fowler N, Wang L, Wang ML. Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL. Blood Adv 4(6):1038-1050, 2020. e-Pub 2020. PMID: 32191807.
67. Xie W, Tang G, Li S, Yin CC, Xu J. Anaplastic multiple myeloma resembling dysplastic megakaryocytes. Clin Case Rep 8(3):568-569, 2020. e-Pub 2020. PMID: 32185061.
68. Shen J, Li S, Medeiros LJ, Lin P, Wang SA, Tang G, Yin CC, You MJ, Khoury JD, Iyer SP, Miranda RN, Xu J. PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma. Mod Pathol 33(3):324-333, 2020. e-Pub 2020. PMID: 31383967.
69. Sakhdari A, Thakral B, Loghavi S, Kanagal-Shamanna R, Yin CC, Zuo Z, Routbort MJ, Luthra R, Medeiros LJ, Wang SA, Patel KP, Ok CY. RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD. Cancer Med 9(3):849-858, 2020. e-Pub 2020. PMID: 31804006.
70. Mankar R, Bueso-Ramos CE, Yin CC, Hidalgo-Lopez JE, Berisha S, Kansiz M, Mayerich D. Automated osteosclerosis grading of clinical biopsies using infrared spectroscopic imaging. Anal Chem, 2020. e-Pub 2020. PMID: 31793292.
71. Bah I, Li S, Yin CC, Tang G, Xu J. Merkel cell carcinoma mimicking transformed chronic lymphocytic leukemia/small lymphocytic lymphoma. Clin Case Rep 7(11):2256-2257, 2019. e-Pub 2019. PMID: 31788294.
72. Hu B, Patel KP, Chen HC, Wang X, Luthra R, Routbort MJ, Kanagal-Shamanna R, Medeiros LJ, Yin CC, Zuo Z, Ok CY, Loghavi S, Tang G, Tambaro FP, Thompson P, Burger J, Jain N, Ferrajoli A, Bose P, Estrov Z, Keating M, Wierda WG. Association of Gene Mutations with Time-to-First Treatment in 384 Treatment-Naive Chronic Lymphocytic Leukaemia Patients. Br J Haematol 187(3):307-318, 2019. e-Pub 2019. PMID: 31243771.
73. Sukswai N, Aung PP, Yin CC, Li S, Wang W, Wang SA, Ortega V, Lyapichev K, Nagarajan P, Alfattal R, Angelova E, Tang Z, Loghavi S, Kanagal-Shamanna R, Miranda RN, Pemmaraju N, Bhalla K, Konopleva M, Medeiros LJ, Khoury JD. Dual Expression of TCF4 and CD123 is Highly Sensitive and Specific for Blastic Plasmacytoid Dendritic Cell Neoplasm. Am J Surg Pathol 43(10):1429-1437, 2019. e-Pub 2019. PMID: 31261288.
74. Li N, Wang SA, Lin P, Jabbour E, Thompson P, Chen Z, Li S, Xu J, You MJ, Bueso-Ramos CE, Medeiros LJ, Yin CC. Relapsed B-Acute Lymphoblastic Leukemia with Aberrant Myeloperoxidase Expression Following CAR T-cell Therapy: A Diagnostic Challenge. Am J Hematol, 2019. e-Pub 2019. PMID: 30916805.
75. Miao Y, Lin P, Saksena A, Xu J, Wang M, Romaguera J, Yin CC, Medeiros LJ, Li S. CD5-negative mantle cell lymphoma: clinicopathologic correlations and outcome in 58 patients. Am J Surg Pathol 43(8):1052-1060, 2019. e-Pub 2019. PMID: 31045891.
76. Sakhdari A, Ok CY, Patel KP, Kanagal-Shamanna R, Yin CC, Zuo Z, Hu S, Routbort MJ, Luthra R, Medeiros LJ, Khoury JD, Loghavi S. TP53 Mutations are Common in Mantle Cell Lymphoma, Including the Indolent Leukemic Non-Nodal Variant. Ann Diagn Pathol 41:38-42, 2019. e-Pub 2019. PMID: 31132650.
77. Saksena A, Yin CC, Xu J, Li J, Zhou J, Wang SA, Lin P, Tang G, Wang L, Wang M, Miranda RN, Medeiros LJ, Li S. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form and a better prognosis. Hum Pathol 89:71-80, 2019. e-Pub 2019. PMID: 31054894.
78. Quesada AE, Routbort MJ, DiNardo CD, Bueso-Ramos CE, Kanagal-Shamanna R, Khoury JD, Thakral B, Zuo Z, Yin CC, Loghavi S, Ok CY, Wang SA, Tang Z, Bannon SA, Benton CB, Garcia-Manero G, Kantarjian H, Luthra R, Medeiros LJ, Patel KP. DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease. Am J Hematol 94(7):757-766, 2019. e-Pub 2019. PMID: 30963592.
79. Richardson AI, Yin CC, Cui W, Li N, Medeiros LJ, Li L, Zhang D. p53 and β-Catenin Expression Predict Poorer Prognosis in Patients With Anaplastic Large-Cell Lymphoma. Clin Lymphoma Myeloma Leuk 19(7):e385-e392, 2019. e-Pub 2019. PMID: 31078446.
80. Hu B, Patel KP, Chen HC, Wang X, Wang F, Luthra R, Routbort MJ, Kanagal-Shamanna R, Medeiros LJ, Yin CC, Zuo Z, Ok CY, Loghavi S, Tang G, Tambaro FP, Thompson P, Burger J, Jain N, Ferrajoli A, Bose P, Estrov Z, Keating MJ, Wierda WG. Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments. Br J Haematol 185(5):852-864, 2019. e-Pub 2019. PMID: 30924136.
81. Xie W, Wang SA, Yin CC, Xu J, Li S, Bueso-Ramos CE, Medeiros LJ, Tang G. Acute myeloid leukemia with t(8;21)(q22;q22.1)/RUNX1-RUNX1T1 and KIT Exon 8 mutation is associated with characteristic mastocytosis and dismal outcomes. Exp Mol Pathol 108:131-136, 2019. e-Pub 2019. PMID: 31004601.
82. Aung PP, Sukswai N, Nejati R, Loghavi S, Chen W, Torres-Cabala CA, Yin CC, Konopleva M, Zheng X, Wang J, Tang Z, Medeiros LJ, Prieto VG, Pemmaraju N, Khoury JD. PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers (Basel) 11(5), 2019. e-Pub 2019. PMID: 31109153.
83. Xu J, Wang L, Li J, Saksena A, Wang SA, Shen J, Hu Z, Lin P, Tang G, Yin CC, Wang M, Medeiros LJ, Li S. SOX11-Negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients. Am J Surg Pathol 43(5):710-716, 2019. e-Pub 2019. PMID: 30768440.
84. Veletic I, Manshouri T, Multani AS, Yin CC, Chen L, Verstovsek S, Estrov Z. Myelofibrosis osteoclasts are clonal and functionally impaired (Imaged selected as the cover page by the journal). Blood 133(21):2320-2324, 2019. e-Pub 2019. PMID: 30745304.
85. Tang Z, Tang G, Hu S, Patel KP, Yin CC, Wang W, Lin P, Toruner GA, Ok CY, Gu J, Lu X, Khoury JD, Medeiros LJ. Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations. Cancer Genet 233-234:21-31, 2019. e-Pub 2019. PMID: 31109591.
86. Hu Z, Ramos CEB, Medeiros LJ, Zhao C, Yin CC, Li S, Hu S, Wang W, Thakral B, Xu J, Verstovsek S, Lin P. Utility of JAK2 V617F Allelic Burden in Distinguishing Chronic Myelomonocytic Leukemia From Primary Myelofibrosis with Monocytosis. Hum Pathol 85:290-298, 2019. e-Pub 2019. PMID: 30447300.
87. Ok CY, Loghavi S, Sui D, Wei P, Kanagal-Shamanna R, Yin CC, Zuo Z, Routbort MJ, Tang G, Tang Z, Jorgensen JL, Luthra R, Ravandi F, Kantarjian HM, DiNardo CD, Medeiros LJ, Wang SA, Patel KP. Persistent IDH1/2 mutation in remission can predict relapse in patients with acute myeloid leukemia. Haematologica 104(2):305-311, 2019. e-Pub 2019. PMID: 30171025.
88. Patel KP, Ruiz-Cordero R, Chen W, Routbort MJ, Floyd K, Rodriguez S, Galbincea J, Barkoh BA, Hatfield D, Khogeer H, Kanagal-Shamanna R, Yin CC, Zuo Z, Loghavi S, Ok CY, DiNardo CD, Luthra R, Medeiros LJ. Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample Collection. J Mol Diagn 21(1):89-98, 2019. e-Pub 2019. PMID: 30577887.
89. Garces S, Yin CC, Patel KP, Khoury JD, Manning JT, Li S, Xu J, Pina-Oviedo S, Johnson MR, González S, Molgó M, Ruiz-Cordero R, Medeiros LJ. Focal Rosai-Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation. Mod Pathol 32(1):16-26, 2019. e-Pub 2019. PMID: 30323237.
90. Liu H, Wang SA, Schlette EJ, Xu J, Jorgensen JL, Yin CC, Li S, Medeiros LJ, Tang G. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1. Ann Hematol 97(10):1775-1783, 2018. e-Pub 2018. PMID: 29872884.
91. Tang Z, Li Y, Wang W, Yin CC, Tang G, Aung PP, Hu S, Lu X, Toruner GA, Medeiros LJ, Khoury JD. Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events. Leuk Res 73:86-94, 2018. e-Pub 2018. PMID: 30248580.
92. Hidalgo-Lopez JE, Kanagal-Shamanna R, Quesada AE, Gong Z, Wang W, Hu S, Medeiros LJ, Bassett RL, d'Orcy E, Yin CC, Cortes J, Jabbour EJ, Kantarjian HM, Bueso-Ramos CE. Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential value. Cancer 124(19):3849-3855, 2018. e-Pub 2018. PMID: 30321462.
93. Li J, Xu J, Abruzzo LV, Tang G, Li S, You MJ, Lu G, Jabbour EJ, Deng Q, Bueso-Ramos CE, Medeiros LJ, Yin CC. Correction: Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of PDGFRA and ETV6. Oncotarget 9(76):34449, 2018. e-Pub 2018. PMID: 30344953.
94. Huang W, Medeiros LJ, Lin P, Wang W, Tang G, Khoury J, Konoplev S, Yin CC, Xu J, Oki Y, Li S. MYC/BCL2/BCL6 Triple Hit Lymphoma: A Study of 40 Patients with a Comparison to MYC/BCL2 and MYC/BCL6 Double Hit Lymphomas. Mod Pathol 31(9):1470-1478, 2018. e-Pub 2018. PMID: 29785017.
95. Verstovsek S, Subbiah V, Masarova L, Yin CC, Tang G, Manshouri T, Asatiani E, Daver NG. Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor. Ann Oncol 29(8):1880-1882, 2018. e-Pub 2018. PMID: 29767670.
96. Jabbar KJ, Yin CC, Bueso-Ramos CE, Luthra R, Medeiros LJ, Zuo Z. Higher body mass index is associated with better survival in patients with myelodysplastic syndromes. Leuk Res 71:63-66, 2018. e-Pub 2018. PMID: 30015105.
97. Kurt H, Jorgensen JL, Amin HM, Patel KP, Wang SA, Lin P, Kanagal-Shamanna R, Loghavi S, Thakral B, Khogeer HA, Jabbour EJ, Li S, Yin CC, Medeiros LJ, Khoury JD. Chronic lymphoproliferative disorder of NK cells: a single-institution review with emphasis on relative utility of multimodality diagnostic tools. Eur J Haematol 100(5):444-454, 2018. e-Pub 2018. PMID: 29385279.
98. Hidalgo López JE, Carballo-Zarate A, Verstovsek S, Wang SA, Hu S, Li S, Xu J, Zuo W, Tang Z, Yin CC, Medeiros LJ, Bueso-Ramos CE, Tang G. Bone marrow findings in blast phase of polycythemia vera. Ann Hematol 97(3):425-434, 2018. e-Pub 2018. PMID: 29285580.
99. Xu J, Medeiros LJ, Saksena A, Wang M, Zhou J, Li J, Yin CC, Tang G, Wang L, Lin P, Li S. CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases. Oncotarget 9(14):11441-11450, 2018. e-Pub 2018. PMID: 29545910.
100. Hu Z, Sun Y, Schlette EJ, Tang G, Li S, Xu J, Yin CC, Young KH, Patel KP, Miranda RN, Goswami M, Wang M, Jorgensen JL, Medeiros LJ, Wang SA. CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course. Mod Pathol 31(2):327-336, 2018. e-Pub 2018. PMID: 28984300.
101. Ng SB, Chung TH, Kato S, Nakamura S, Takahashi E, Ko YH, Khoury JD, Yin CC, Soong R, Jeyasekharan AD, Hoppe MM, Selvarajan V, Tan SY, Lim ST, Ong CK, Nairismägi ML, Maheshwari P, Choo SN, Fan S, Lee CK, Chuang SS, Chng WJ. Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes. Haematologica 103(2):278-287, 2018. e-Pub 2018. PMID: 29097495.
102. Quesada AE, Hu Z, Routbort MJ, Patel KP, Luthra R, Loghavi S, Zuo Z, Yin CC, Kanagal-Shamanna R, Wang SA, Jorgensen JL, Medeiros LJ, Ok CY. Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing. Oncotarget 9(9):8441-8449, 2018. e-Pub 2018. PMID: 29492206.
103. Li J, Xu J, Abruzzo LV, Tang G, Li S, You MJ, Lu G, Jabbour EJ, Deng Q, Bueso-Ramos CE, Medeiros LJ, Yin CC. Acute myeloid leukemia with t(4;12)(q12;p13): An aggressive disease with frequent involvement of PDGFRA and ETV6. Oncotarget 9(13):10987-10994, 2018. e-Pub 2018. PMID: 29541391.
104. Quesada AE, Medeiros LJ, Desai PA, Lin P, Westin JR, Hawsawi HM, Wei P, Tang G, Seegmiller AC, Reddy NM, Yin CC, Wang W, Xu J, Miranda RN, Zuo Z, Li S. Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma. Mod Pathol 30(12):1688-1697, 2017. e-Pub 2017. PMID: 28776574.
105. Zhang H, Li L, Wang Y, Yin CC, Xie Y, Liu X, Ding H, Tian Z, Shen J, He L, Xia M, Ma X, Wu L. Functional analysis of BRCT missense mutations in BRCA1-mutated Chinese Han familial breast cancer. Oncol Lett 14(5):5839-5844, 2017. e-Pub 2017. PMID: 29113215.
106. Kanagal-Shamanna R, Jain P, Takahashi K, Short NJ, Tang G, Issa GC, Ravandi F, Garcia-Manero G, Yin CC, Luthra R, Patel KP, Khoury JD, Montalban-Bravo G, Sasaki K, Kadia TM, Borthakur G, Konopleva M, Jain N, Garris R, Pierce S, Wierda W, Estrov Z, Cortes J, O'Brien S, Kantarjian HM, Jabbour E. TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens. Cancer 123(19):3717-3724, 2017. e-Pub 2017. PMID: 28608976.
107. Jain P, Kantarjian H, Jain N, Short NJ, Yin CC, Kanagal-Shamanna R, Khoury J, Konopleva M, Sasaki K, Kadia TM, Garris R, Pierce S, Estrov Z, Wierda W, Cortes J, O'Brien S, Ravandi F, Jabbour E. Clinical characteristics and outcomes of previously untreated patients with adult onset T-ALL and T-lymphoblastic lymphoma (T-LL) with hyper-CVAD based regimens. Am J Hematol 92(10):E595-E597, 2017. e-Pub 2017. PMID: 28646517.
108. Xue Y, Han H, Wu L, Pan B, Dong B, Yin CC, Tian Z, Liu X, Yang Y, Zhang H, Chen Y, Chen J. iASPP facilitates tumor growth by promoting mTOR-dependent autophagy in human non-small cell lung cancer. Cell Death Dis 8(10):e3150, 2017. e-Pub 2017. PMID: 29072696.
109. Garces S, Medeiros LJ, Patel KP, Li S, Pina-Oviedo S, Li J, Garces JC, Khoury JD, Yin CC. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease. Mod Pathol 30(10):1367-1377, 2017. e-Pub 2017. PMID: 28664935.
110. Tang G, Hidalgo Lopez JE, Wang SA, Hu S, Ma J, Pierce S, Zuo W, Carballo-Zarate AA, Yin CC, Tang Z, Li S, Medeiros LJ, Verstovsek S, Bueso-Ramos CE. Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera. Haematologica 102(9):1511-1518, 2017. e-Pub 2017. PMID: 28473622.
111. Hidalgo-López JE, Kanagal-Shamanna R, Medeiros LJ, Estrov Z, Yin CC, Verstovsek S, Konoplev S, Jorgensen JL, Mohammad MM, Miranda RN, Zhao C, Lee J, Zuo Z, Bueso-Ramos CE. Morphologic and molecular characteristics of de novo AML with JAK2 V617F mutation. J Natl Compr Canc Netw 15(6):790-796, 2017. e-Pub 2017. PMID: 28596259.
112. Pina-Oviedo S, Medeiros LJ, Li S, Khoury JD, Patel KP, Alayed K, Cason RC, Bowman CJ, Yin CC. Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations. Mod Pathol 30(5):734-744, 2017. e-Pub 2017. PMID: 28084334.
113. Khan M, Yin CC, Yates A, Newberry KJ, Verstovsek S. A rare case of primary myelofibrosis in a 14-year-old patient with congenital asplenia. J Pediatr Hematol Oncol 39(4):e196-e198, 2017. e-Pub 2017. PMID: 27403772.
114. Thakral B, Medeiros LJ, Desai P, Lin P, Yin CC, Tang G, Khoury JD, Hu S, Xu J, Loghavi S, Hu B, Oki Y, Li S. Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCH. Eur J Haematol 98(4):415-421, 2017. e-Pub 2017. PMID: 28039906.
115. Short NJ, Kantarjian HM, Sasaki K, Ravandi F, Ko H, Yin CC, Garcia-Manero G, Cortes JE, Garris R, O'Brien SM, Patel K, Khouri M, Thomas D, Jain N, Kadia TM, Daver NG, Benton CB, Issa GC, Konopleva M, Jabbour E. Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor. Am J Hematol 92(3):238-243, 2017. e-Pub 2017. PMID: 28006851.
116. Issa GC, Kantarjian HM, Yin CC, Qiao W, Ravandi F, Thomas D, Short NJ, Sasaki K, Garcia-Manero G, Kadia TM, Cortes JE, Daver N, Borthakur G, Jain N, Konopleva M, Khouri I, Kebriaei P, Champlin RE, Pierce S, O'Brien SM, Jabbour E. Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease. Cancer 123(3):459-467, 2017. e-Pub 2017. PMID: 27696391.
117. Xu J, Oki Y, Saksena A, Desai P, Lin P, Tang G, Yin CC, You MJ, Thakral B, Medeiros LJ, Li S. CD30 expression and prognostic significance in R-EPOCH treated patients with diffuse large B-cell lymphoma. Hum Pathol 60:160-166, 2017. e-Pub 2017. PMID: 27816715.
118. Boddu P, Yin CC, Kanagal-Shamanna R, Tang G, Thakral B, Kadia T, Konopleva M, Jabbour E, Jain N. An unusual finding of t (9;22): a rare case of Philadelphia chromosome-positive B-lymphoblastic lymphoma. Case Rep Hematol 2017:2413587, 2017. e-Pub 2017. PMID: 29075538.
119. Masarova L, Yin CC, Cortes JE, Konopleva M, Borthakur G, Newberry KJ, Kantarjian HM, Bueso-Ramos CE, Verstovsek S. Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV). Exp Hematol Oncol 6:30, 2017. e-Pub 2017. PMID: 29152412.
120. Wang W, Chen Z, Hu Z, Yin CC, Li S, Bai S, Bueso-Ramos CE, Medeiros LJ, Hu S. Clinical significance of trisomy 8 that emerges during therapy in chronic myeloid leukemia. Blood Cancer J 6(11):e490, 2016. e-Pub 2016. PMID: 27813536.
121. Yin CC, Peng J, Li Y, Shamanna RK, Muzzafar T, DiNardo C, Khoury JD, Li S, Medeiros LJ, Wang SA, Tang G. Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies. Mod Pathol 29(8):939, 2016. e-Pub 2016. PMID: 27469452.
122. Hidalgo Lopez JE, Yabe M, Carballo-Zarate AA, Wang SA, Jorgensen JL, Ahmed S, Lee J, Li S, Schlette E, McDonnell T, Miranda RN, Medeiros LJ, Bueso-Ramos CE, Yin CC. Donor-derived T-cell large granular lymphocytic leukemia in a patient with peripheral T-cell lymphoma. J Natl Compr Canc Netw 14(8):939-44, 2016. e-Pub 2016. PMID: 27496109.
123. Chen Z, Cortes JE, Jorgensen JL, Wang W, Yin CC, You MJ, Jabbour E, Kantarjian HM, Medeiros LJ, Hu S. Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Leukemia 30(7):1606-9, 2016. e-Pub 2016. PMID: 26837843.
124. Alayed K, Medeiros LJ, Patel KP, Zuo Z, Li S, Verma S, Galbincea J, Cason RC, Luthra R, Yin CC. BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases. Hum Pathol 52:61-7, 2016. e-Pub 2016. PMID: 26980021.
125. Jain P, Tang G, Huh YO, Yin CC, Zuo Z, Pemmaraju N, Estrov Z, Daver N. Philadelphia-positive dimorphic blasts in mixed-phenotype acute leukemia with TET2 mutation. Am J Hematol 91(6):647-8, 2016. e-Pub 2016. PMID: 26799924.
126. Li S, Saksena A, Desai P, Xu J, Zuo Z, Lin P, Tang G, Yin CC, Seegmiller A, Jorgensen JL, Miranda RN, Reddy NM, Bueso-Ramos C, Medeiros LJ. Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphoma. Oncotarget 7(25):38122-38132, 2016. e-Pub 2016. PMID: 27203548.
127. Aung FM, Lichtiger B, Rondon G, Yin CC, Alousi A, Ahmed S, Andersson BS, Bashir Q, Ciurea SO, Hosing C, Jones R, Kebriaei P, Khouri I, Nieto Y, Oran B, Parmar S, Qazilbash M, Shah N, Shpall EJ, Champlin RE, Popat U. Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia. Biol Blood Marrow Transplant 22(5):961-5, 2016. e-Pub 2016. PMID: 26921820.
128. Hong M, Hao S, Patel KP, Kantarjian HM, Garcia-Manero G, Yin CC, Medeiros LJ, Lin P, Lu X. Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a unique molecular-cytogenetic subgroup. Cancer Genet 209(5):205-14, 2016. e-Pub 2016. PMID: 27134073.
129. Aye le L, Loghavi S, Young KH, Siddiqi I, Yin CC, Routbort MJ, Liang M, Eilerman K, Medeiros LJ, Brynes RK, Bueso-Ramos C. Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 cases. Ann Diagn Pathol 21:53-8, 2016. e-Pub 2016. PMID: 27040932.
130. Kanagal-Shamanna R, Luthra R, Yin CC, Patel KP, Takahashi K, Lu X, Lee J, Zhao C, Stingo F, Zuo Z, Routbort MJ, Singh RR, Fox P, Ravandi F, Garcia-Manero G, Medeiros LJ, Bueso-Ramos CE. Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS. Oncotarget 7(12):14251-8, 2016. e-Pub 2016. PMID: 26883102.
131. Wu L, Yao L, Zhang H, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Yin CC, Xie Y. A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin, and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients. Oncotarget 7(4):5042-52, 2016. e-Pub 2016. PMID: 26573232.
132. Li S, Weiss VL, Wang XJ, Desai PA, Hu S, Yin CC, Tang G, Reddy NM, Medeiros LJ, Lin P. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis. Am J Surg Pathol 40(2):253-61, 2016. e-Pub 2016. PMID: 26448193.
133. Li S, Desai P, Lin P, Yin CC, Tang G, Wang XJ, Konoplev SN, Khoury JD, Bueso-Ramos CE, Medeiros LJ. MYC/BCL6 double hit lymphoma (DHL): A tumor associated with an aggressive clinical course and poor prognosis. Histopathology 68(7):1090-8, 2016. e-Pub 2016. PMID: 26426741.
134. Tang Z, Medeiros LJ, Yin CC, Wang W, Lu X, Young KH, Khoury JD, Tang G. Sex chromosome loss after allogeneic hematopoietic stem cell transplant in patients with hematologic neoplasms: A diagnostic dilemma for clinical cytogeneticists. Mol Cytogenet 9:62-68, 2016. e-Pub 2016. PMID: 27508005.
135. Liu J, Xia M, Wang P, Wang C, Geng Z, Yin CC, Qiu X. Immunoglobulin gene expression in umbilical cord blood-derived CD34+ hematopoietic stem/progenitor cells. Gene 575:108-17, 2016. e-Pub 2016.
136. Wang C, Xia M, Sun X, He Z, Hu F, Chen L, Bueso-Ramos CE, Qiu X, Yin CC. IGK with conserved IG?V/IG?J repertoire is expressed in acute myeloid leukemia and promotes leukemic cell migration. Oncotarget 6(36):39062-72, 2015. e-Pub 2015. PMID: 26429876.
137. Loghavi S, Al-Ibraheemi A, Zuo Z, Garcia-Manero G, Yabe M, Wang SA, Kantarjian HM, Yin CC, Miranda RN, Luthra R, Medeiros LJ, Bueso-Ramos CE, Khoury JD. TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis. Br J Haematol 171(1):91-9, 2015. e-Pub 2015. PMID: 26123119.
138. Yin CC, Peng J, Li Y, Shamanna RK, Muzzafar T, DiNardo C, Khoury JD, Li S, Medeiros LJ, Wang SA, Tang G. Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies. Mod Pathol 28(8):1014-22, 2015. e-Pub 2015. PMID: 26044451.
139. Chakhachiro Z, Yin CC, Abruzzo LV, Aladily TN, Barron LL, Banks HE, Thomas DA, Keating M, Medeiros LJ, Huh YO. B-lymphoblastic leukemia in patients with chronic lymphocytic leukemia: a report of four cases. Am J Clin Pathol 144(2):333-40, 2015. e-Pub 2015. PMID: 26185320.
140. Loghavi S, Alayed K, Aladily TN, Zuo Z, Ng SB, Tang G, Hu S, Yin CC, Miranda RN, Medeiros LJ, Khoury JD. Stage, age and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients. J Hematol Oncol 10(8):65-75, 2015. e-Pub 2015. PMID: 26055271.
141. Cao X, Ye Q, Orlowski RZ, Wang X, Loghavi S, Tu M, Thomas SK, Shan J, Li S, Qazilbash M, Yin CC, Weber D, Miranda RN, Xu-Monette ZY, Medeiros LJ, Young KH. Waldenström macroglobulinemia with extramedullary involvement at initial diagnosis portends a poorer prognosis. J Hematol Oncol 8:74, 2015. e-Pub 2015. PMID: 26104577.
142. Li Y, Hu S, Zuo Z, Hong M, Lin P, Li S, Konoplev S, Wang Z, Khoury JD, Young KH, Medeiros LJ, Yin CC. CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases. Mod Pathol 28(6):787-98, 2015. e-Pub 2015. PMID: 25743023.
143. Wang XI, Yin CC, Qazilbash MH, Hu S, Lu G. Clinical Significance of Acquired Cytogenetic Clones in Patients With Treated Follicular Lymphoma. Clin Lymphoma Myeloma Leuk 15(5):262-9, 2015. e-Pub 2015. PMID: 25573378.
144. Yin CC, Jain N, Mehrotra M, Zhang J, Protopopov A, Zuo Z, Pemmaraju N, DiNardo C, Hirsch-Ginsberg C, Wang SA, Medeiros LJ, Chin L, Patel KP, Ravandi F, Futreal A, Bueso-Ramos CE. Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia. J Natl Compr Canc Netw 13(1):19-22, 2015. e-Pub 2015. PMID: 25583766.
145. Goswami RS, Liang CS, Bueso-Ramos CE, Hu S, Goswami M, Yin CC, Lu G, Medeiros LJ, Tang G. Isolated +15 in bone marrow: Disease-associated or a benign finding?. Leuk Res 39(1):72-6, 2015. e-Pub 2015. PMID: 25435027.
146. Liao Q, Liu W, Liu Y, Wang F, Wang C, Zhang J, Chu M, Jiang D, Xiao L, Shao W, Sheng Z, Tao X, Huo L, Yin CC, Zhang Y, Lee G, Huang J, Li Z, Qiu X. Aberrant high expression of immunoglobulin G in epithelial stem/progenitor-like cells contributes to tumor initiation and metastasis. Oncotarget 6(37):40081-94, 2015. e-Pub 2015. PMID: 26472025.
147. Yin CC, Tang G, Lu G, Feng X, Keating MJ, Medeiros LJ, Abruzzo LV. Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cells (received Ten Best Pathology Papers award by MKLinx Pathology). Mod Pathol 28(8):1130-7, 2015. e-Pub 2015. PMID: 25953391.
148. Wang W, Tang G, Cortes JE, Liu H, Ai D, Yin CC, Li S, Khoury JD, Bueso-Ramos C, Medeiros LJ, Hu S. Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis. J Hematol Oncol 8(1):32-8, 2015. e-Pub 2015. PMID: 25888368.
149. Wang XJ, Medeiros LJ, Lin P, Yin CC, Hu S, Thompson MA, Li S. MYC Cytogenetic Status Correlates With Expression and Has Prognostic Significance in Patients With MYC/BCL2 Protein Double-positive Diffuse Large B-cell Lymphoma. Am J Surg Pathol 39(9):1250-8, 2015. e-Pub 2015. PMID: 25828389.
150. Liu Y, Liu D, Wang C, Liao Q, Huang J, Jiang D, Shao W, Yin CC, Zhang Y, Lee G, Qiu X. Binding of the mAb RP215 to IgG in metastatic lung adenocarcinomas is correlated with poor prognosis. Histopathology 67(5):645-53, 2015. e-Pub 2015. PMID: 25753759.
151. Liu H, Wang W, Tang G, Yin CC, Muzzafar T, Medeiros LJ, Hu S. Lymphomatous variant of hairy cell leukemia: a distinctive presentation mimicking low-grade B-cell lymphoma. Histopathology 67(5):740-5, 2015. e-Pub 2015. PMID: 25809821.
152. Jabbour E, Kantarjian H, Ravandi F, Thomas D, Huang X, Faderl S, Pemmaraju N, Daver N, Garcia-Manero G, Sasaki K, Cortes J, Garris R, Yin CC, Khoury JD, Jorgensen J, Estrov Z, Bohannan Z, Konopleva M, Kadia T, Jain N, DiNardo C, Wierda W, Jeanis V, O'Brien S. Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study. Lancet Oncol 16(15):1547-55, 2015. e-Pub 2015. PMID: 26432046.
153. Ma H, Mallampati S, Lu Y, Sun B, Wang E, Leng X, Gong Y, Shen H, Yin CC, Jones D, Amin HM, You MJ, Zweidler-McKay P, Ma Y, Kantarjian HM, Arlinghaus RB, Glassman A, Sun X. Sox4/Tcf7l1 axis promotes progression of BCR-ABL+ acute lymphoblastic leukemia. Haematologica 99(10):1591-8, 2014. e-Pub 2014. PMID: 24997151.
154. Tang G, Wang SA, Lu V, Lee HC, Qazilbash MH, Wang XI, Yin CC, Orlowski R, Wang Y, Patel A, Medeiros LJ, Lu G. Clinically silent clonal cytogenetic abnormalities arising in patients treated for lymphoid neoplasms. Leuk Res 38(8):896-900, 2014. e-Pub 2014. PMID: 24939217.
155. Wang S, Medeiros LJ, Xu-Monette ZY, Zhang S, O'Malley DP, Orazi A, Zuo Z, Bueso-Ramos CE, Yin CC, Liu Z, Miranda RN, Young KH. Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma. Ann Diagn Pathol 18(4):203-9, 2014. e-Pub 2014. PMID: 24852241.
156. Dai CW, Bai QW, Zhang GS, Cao YX, Shen JK, Pei MF, Yin CC. MicroRNA let-7f is down-regulated in patients with refractory acute myeloid leukemia and is involved in chemotherapy resistance of adriamycin-resistant leukemic cells. Leuk Lymphoma 55(7):1645-8, 2014. e-Pub 2014. PMID: 24067109.
157. Ok CY, Yin CC, Yabe M, Bueso-Ramos CE, Miranda RN, Medeiros LJ, Konoplev SN. Lymphoma with Features Intermediate Between Aggressive T-Large Granular Lymphocytic Leukemia and Hepatosplenic T-Cell Lymphoma: a Diagnostic Dilemma?. Clin Lymphoma Myeloma Leuk 14(3):e95-100, 2014. e-Pub 2014. PMID: 24524924.
158. DiNardo CD, Daver N, Jain N, Pemmaraju N, Bueso-Ramos C, Yin CC, Pierce S, Jabbour E, Cortes JE, Kantarjian HM, Garcia-Manero G, Verstovsek S. Myelodysplastic/Myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): Natural history and clinical outcome by treatment strategy. Leukemia 28(4):958-61, 2014. e-Pub 2014. PMID: 24492324.
159. Jaso JM, Yin CC, Lu VW, Zhao M, Abruzzo LV, You MJ, Yang Y, Luthra R, Medeiros LJ, Lu G. B-acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH/EPOR: a clinically aggressive subset of disease. Mod Pathol 27(3):382-9, 2014. e-Pub 2014. PMID: 24030742.
160. Huang J, Sun X, Gong X, He Z, Chen L, Qiu X, Yin CC. Rearrangement and expression of the immunoglobulin μ-chain gene in human myeloid cells. Cell Mol Immunol 11(1):94-104, 2014. e-Pub 2014. PMID: 24141767.
161. Wang XI, Lu X, Yin CC, Zhao L, Bueso-Ramos CE, Medeiros LJ, Li S, Rogers J, Hsi ED, Lin P. Myeloid neoplasm associated with t(3;12)(q26.2;p13) are clinically aggressive and frequently harbor FLT3 mutations. J Leukemia 2:161, 2014. e-Pub 2014.
162. Jaso JM, Yin CC, Wang SA, Miranda RN, Jabcuga CE, Chen L, Medeiros LJ. Clinicopathologic features of CD5-positive nodal marginal zone lymphoma. Am J Clin Pathol 140(5):693-700, 2013. e-Pub 2013. PMID: 24124149.
163. Hu S, Bueso-Ramos CE, Verstovsek S, Miranda RN, Yin CC, McDonnell T, Medeiros LJ, Lin P. Metastatic Splenic Angiosarcoma Presenting With Thrombocytopenia and Bone Marrow Fibrosis Mimicking Idiopathic Thrombocytopenic Purpura and Primary Myelofibrosis: A Diagnostic Challenge. Clin Lymphoma Myeloma Leuk 13(5):629-33, 2013. e-Pub 2013. PMID: 23800601.
164. Zhou Y, Fan X, Routbort M, Yin CC, Singh R, Bueso-Ramos C, Thomas DA, Milton DR, Medeiros LJ, Lin P. Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high risk adult T-lymphoblastic leukemia/lymphoma. Mod Pathol 26(10):1338-45, 2013. e-Pub 2013. PMID: 23702731.
165. Benjamini O, Jain P, Konoplev SN, Yin CC, Abruzzo L, Wotherspoon AC, Dearden C, Shpall EJ, Estrov Z, Keating MJ. CD4(-)/CD8(-) Variant of T-Cell Large Granular Lymphocytic Leukemia or Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Dilemma. Clin Lymphoma Myeloma Leuk 13(5):610-3, 2013. e-Pub 2013. PMID: 23800602.
166. Li S, Lin P, Young KH, Kanagal-Shamanna R, Yin CC, Medeiros LJ. MYC/BCL2 double-hit high-grade B-cell lymphoma. Adv Anat Pathol 20(5):315-26, 2013. e-Pub 2013. PMID: 23939148.
167. Lu G, Schulz RA, Bueso-Ramos CE, Cortes JE, Iris Wang X, Medeiros LJ, Yin CC. Double-hit of FLT3 gene in a fatal case of acute myemonocytic leukaemia. J Clin Pathol 66(9):826-9, 2013. e-Pub 2013. PMID: 23703854.
168. Kanagal-Shamanna R, Yin CC, Miranda RN, Bueso-Ramos CE, Wang XI, Muddasani R, Medeiros LJ, Lu G. Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q). Cancer Genet 206(1-2):42-6, 2013. e-Pub 2013. PMID: 23357231.
169. Qiu X, Sun X, He Z, Huang J, Hu F, Chen L, Lin P, You MJ, Medeiros LJ, Yin CC. Immunoglobulin gamma heavy chain gene with somatic hypermutation is frequently expressed in acute myeloid leukemia (Received one of the 20 Diploma of Excellence Awards by Leukemia). Leukemia 27(1):92-9, 2013. e-Pub 2013. PMID: 22772058.
170. Konoplev S, Yin CC, Kornblau SM, Kantarjian HM, Konopleva M, Andreeff M, Lu G, Zuo Z, Luthra R, Medeiros LJ, Bueso-Ramos CE. Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia. Leuk Lymphoma 54(1):138-44, 2013. e-Pub 2013. PMID: 22691121.
171. Li S, Feng X, Li T, Zhang S, Zuo Z, Lin P, Konoplev S, Bueso-Ramos CE, Vega F, Medeiros LJ, Yin CC. Extranodal NK/T-Cell lymphoma, nasal type: A report of 73 cases at MD Anderson Cancer Center. Am J Surg Pathol 37(1):14-23, 2013. e-Pub 2013. PMID: 23232851.
172. Hoehn D, Lu G, Konoplev S, Zhou Y, Bueso-Ramos CE, Zuo Z, Hsu B, Medeiros LJ, Yin CC. t(15;17)(q24.1;q21.2)/PML-RARA in blast phase of chronic myelogenous leukemia: a rare form of clonal evolution. J Hematopathol 6(4):187-93, 2013. e-Pub 2013.
173. Konoplev S, Lin P, Yin CC, Lin E, Nogueras González GM, Kantarjian HM, Andreeff M, Medeiros LJ, Konopleva M. CXC Chemokine Receptor 4 Expression, CXC Chemokine Receptor 4 Activation, and Wild-Type Nucleophosmin Are Independently Associated With Unfavorable Prognosis in Patients With Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk 13(6):686-92, 2013. e-Pub 2013. PMID: 24035716.
174. Jabbour E, Morris V, Kantarjian H, Yin CC, Burton E, Cortes J. Characteristics and outcomes of patients with V299L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors. Blood 120(16):3382-3, 2012. e-Pub 2012. PMID: 23086624.
175. Li S, Yin CC, Medeiros LJ, Bueso-Ramos C, Lu G, Lin P. Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome. Am J Clin Pathol 138(1):146-52, 2012. e-Pub 2012. PMID: 22706870.
176. Warren M, Luthra R, Yin CC, Ravandi F, Cortes JE, Kantarjian HM, Medeiros LJ, Zuo Z. Clinical impact of change of FLT3 mutation status in acute myeloid leukemia patients. Mod Pathol 25(10):1405-12, 2012. e-Pub 2012. PMID: 22684224.
177. Li S, Lin P, Fayad LE, Lennon PA, Miranda RN, Yin CC, Lin E, Medeiros LJ. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome. Mod Pathol 25(1):145-56, 2012. e-Pub 2012. PMID: 22002575.
178. Aladily TN, Nathwani BN, Miranda RN, Kansal R, Yin CC, Protzel R, Takowsky GS, Medeiros LJ. Extranodal NK/T-cell lymphoma, nasal type arising in association with saline breast implant: expanding the spectrum of breast implant-associated lymphomas. Am J Surg Pathol 36(11):1729-34, 2012. e-Pub 2012. PMID: 23073330.
179. Bai B, Lu G, Yin CC. t(1;3)(p36;p21) as the sole clonal abnormality in a case of refractory acute myeloid leukemia. N Am J Med Sci 5(4):235-8, 2012. e-Pub 2012.
180. Kanagal-Shamanna R, Bueso-Ramos CE, Barkoh B, Lu G, Wang S, Garcia-Manero G, Vadhan-Raj S, Hoehn D, Medeiros LJ, Yin CC. Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53. Cancer 118(11):2879-88, 2012. e-Pub 2012. PMID: 22038701.
181. Hu F, Zhang L, Zheng J, Zhao L, Huang J, Shao W, Liao Q, Ma T, Geng L, Yin CC, Qiu X. Spontaneous production of immunoglobulin m in human epithelial cancer cells. PLoS One 7(12):e51423, 2012. e-Pub 2012. PMID: 23251529.
182. Hoehn D, Yin CC, Chen L, Sheridan G, Wenig BM. Diagnosing hypocellular collagenized spindle cell squamous carcinoma of the head and neck: A rare subtype with misleading histologic features. N Am J Med Sci 5(1):9-12, 2012. e-Pub 2012.
183. Ohanian M, Leventaki V, Verstovsek S, Estrov Z, Lin P, Yin CC, Kantarjian H, Huh Y, Ravandi F. Acute lymphoblastic leukemia arising in post-polycythemic myelofibrosis: a rare entity. Leuk Lymphoma 53(9):1839-41, 2012. e-Pub 2012. PMID: 22303899.
184. Hoehn D, Yin CC. Unusual presentation of a dysembryoplastic neuroepithelial tumor mimicking a pontomesencephalic cavernous hemangioma. J Med Cases 3(6):375-8, 2012. e-Pub 2012.
185. Bai B, Zuo Z, Cheong SH, Vo B, Harper E, Lovshe D, Yang S, Yin CC. Novel chromosomal aberration as evidence of clonal evolution in a case of relapsed acute myeloid leukemia. N Am J Med Sci 5(1):48-50, 2012. e-Pub 2012.
186. Jaso J, Chen L, Li S, Lin P, Chen W, Miranda RN, Konoplev S, Medeiros LJ, Yin CC. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases. Hum Pathol 43(9):1436-43, 2012. e-Pub 2012. PMID: 22406370.
187. Sun J, Yin CC, Cui W, Chen SS, Medeiros LJ, Lu G. Chromosome 20q deletion - a recurrent cytogenetic abnormality in patients with chronic myelogenous leukemia in remission. Am J Clin Pathol 135(3):391-7, 2011. e-Pub 2011. PMID: 21350093.
188. Gurevich I, Luthra R, Konoplev SN, Yin CC, Medeiros LJ, Lin P. Refractory anemia with ring sideroblasts associated with marked thrombocytosis: a mixed group exhibiting a spectrum of morphologic findings. Am J Clin Pathol 135(3):398-403, 2011. e-Pub 2011. PMID: 21350094.
189. Barakat FH, Luthra R, Yin CC, Barkoh BA, Hai S, Jamil W, Bhakta YI, Chen S, Medeiros LJ, Zuo Z. Detection of nucleophosmin 1 mutations by quantitative real-time polymerase chain reaction versus capillary electrophoresis: a comparative study. Arch Pathol Lab Med 135(8):994-1000, 2011. e-Pub 2011. PMID: 21809990.
190. Hoehn D, Bala KK, Fan W, Yin CC. Parinaud oculoglandular syndrome as a prominent presenting feature of Kikuchi-Fujimoto disease. N Am J Med Sci 4(2):96-9, 2011. e-Pub 2011.
191. Yin CC, Cortes J, Galbincea J, Reddy N, Breeden M, Jabbour E, Luthra R, Jones D. Rapid clonal shifts in response to kinase inhibitor therapy in chronic myelogenous leukemia are identified by quantitation mutation assays. Cancer Sci 101(9):2005-10, 2010. e-Pub 2010. PMID: 20557306.
192. Zhu X, Wu L, Zhang L, Hao P, Zhang S, Huang J, Zheng J, Liu Y, Li W, Zhang Y, Zhou C, Zhang Y, Yin CC, Qiu X. Distinct regulatory mechanism of immunoglobulin gene transcription in epithelial cancer cells. Cell Mol Immunol 7(4):279-86, 2010. e-Pub 2010. PMID: 20473321.
193. Konoplev S, Lin P, Qiu X, Medeiros LJ, Yin CC. Clonal relationship of extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue involving different sites. Am J Clin Pathol 134(1):112-8, 2010. e-Pub 2010. PMID: 20551275.
194. Talwalkar SS, Yin CC, Naeem RC, Hicks MJ, Strong LC, Abruzzo LV. Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome. Arch Pathol Lab Med 134(7):1010-5, 2010. e-Pub 2010. PMID: 20586629.
195. Li T, Medeiros LJ, Lin P, Yin H, Littlejohn M, Im W, Lennon PA, Hu P, Jorgensen JL, Liang M, Guo H, Yin CC. Immunohistochemical profile and fluorescence in situ hybridization analysis of diffuse large B-cell lymphoma in northern China. Arch Pathol Lab Med 134(5):759-65, 2010. e-Pub 2010. PMID: 20441508.
196. Liang M, Han X, Vadhan-Raj S, Nguyen M, Zhang YH, Fernandez M, Drakos E, Konoplev SN, Yin CC, Miranda RN, McDonnell TJ, Medeiros LJ, Bueso-Ramos CE. HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis. Mod Pathol 23(3):381-91, 2010. e-Pub 2010. PMID: 20062013.
197. Zhang S, Mao Y, Huang J, Ma T, Zhang L, Zhu X, Zheng J, Wu L, Yin CC, Qiu X. Immunoglobulin gene locus events in epithelial cells of lactating mouse mammary glands. Cell Mol Life Sci 67(6):985-94, 2010. e-Pub 2010. PMID: 20033753.
198. Cui W, Bueso-Ramos CE, Yin CC, Sun J, Chen S, Muddasani R, Lu G. Trisomy 14 as a sole chromosome abnormality is associated with older age, a heterogenous group of myeloid neoplasms with dysplasia and a wide spectrum of disease progression. J Biomed Biotechnol 2010:365318-24, 2010. e-Pub 2010. PMID: 21331167.
199. Lin P, Lennon PA, Yin CC, Abruzzo LV. Chronic myeloid leukemia in blast phase associated with t(3;8)(q26;q24). Cancer Genet Cytogenet 193(2):119-22, 2009. e-Pub 2009. PMID: 19665075.
200. Yin CC, Abruzzo LV, Qiu X, Apostolidou E, Cortes JE, Medeiros LJ, Lu G. Del(15q) is a recurrent "minor route" cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemia. Cancer Genet Cytogenet 192(1):18-23, 2009. e-Pub 2009. PMID: 19480932.
201. Yin CC, Lin KI, Ketterling RP, Knudson RA, Medeiros LJ, Barron LL, Huh YO, Luthra R, Keating MJ, Abruzzo LV. Chronic lymphocytic leukemia With t(2;14)(p16;q32) involves the BCL11A and IgH genes and is associated with atypical morphologic features and unmutated IgVH genes. Am J Clin Pathol 131(5):663-70, 2009. e-Pub 2009. PMID: 19369625.
202. Zheng J, Huang J, Mao Y, Liu S, Sun X, Zhu X, Ma T, Zhang L, Ji J, Zhang Y, Yin CC, Qiu X. Immunoglobulin gene transcripts have distinct VHDJH recombination characteristics in human epithelial cancer cells. J Biol Chem 284(20):13610-9, 2009. e-Pub 2009. PMID: 19293154.
203. Jones D, Thomas D, Yin CC, O'Brien S, Cortes JE, Jabbour E, Breeden M, Giles FJ, Zhao W, Kantarjian HM. Kinase domain point mutations in Ph+ acute lymphoblastic leukemia (ALL) emerge following therapy with BCR-ABL kinase inhibitors. Cancer 113(5):985-94, 2008. e-Pub 2008. PMID: 18615627.
204. Huh YO, Lin KI, Vega F, Schlette E, Yin CC, Keating MJ, Luthra R, Medeiros LJ, Abruzzo LV. Myc translocation in chronic lymphocytic leukemia is associated with increased prolymphocytes and a poor prognosis. Br J Haematol 142(1):36-44, 2008. e-Pub 2008. PMID: 18477041.
205. Atallah E, Nussenzveig R, Yin CC, Bueso-Ramos C, Tam C, Manshouri T, Pierce S, Kantarjian H, Verstovsek S. Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis. Leukemia 22(6):1295-8, 2008. e-Pub 2008. PMID: 18059483.
206. Feng X, Ying J, Yin CC, Li L, Shi S, Zhang H, Sun Y. Diagnosis and differential diagnoses of granulocytic sarcoma. Chinese-German J Clin Oncol 7:603-7, 2008. e-Pub 2008.
207. Cortes J, Jabbour E, Kantarjian H, Yin CC, Shan J, O'Brien S, Garcia-Manero G, Giles F, Breeden M, Reeves N, Wierda WG, Jones D. Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors. Blood 110(12):4005-11, 2007. e-Pub 2007. PMID: 17785585.
208. Lennon PA, Abruzzo LV, Medeiros LJ, Cromwell C, Zhang X, Yin CC, Kornblau SM, Konopleva M, Lin P. Aberrant EVI1 expression in acute myeloid leukemias associated with the t(3;8)(q26;q24). Cancer Genet Cytogenet 177(1):37-42, 2007. e-Pub 2007. PMID: 17693189.
209. Yin CC, Medeiros LJ, Cromwell CC, Mehta AP, Lin P, Luthra R, Abruzzo LV. Sequence analysis proves clonal identity in five patients with typical and blastoid mantle cell lymphoma. Mod Pathol 20(1):1-7, 2007. e-Pub 2007. PMID: 17057651.
210. Salvato MS, Yin CC, Yagita H, Maeda T, Okumura K, Tikhonov I, Pauza CD. Attenuated disease in SIV-infected macaques treated with a monoclonal antibody against FasL. Clin Dev Immunol 2007:93462-6, 2007. e-Pub 2007. PMID: 18317535.
211. Lin P, Medeiros LJ, Yin CC, Abruzzo LV. Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia. Cancer Genet Cytogenet 166(1):82-5, 2006. e-Pub 2006. PMID: 16616115.
212. Yin CC, Cortes J, Barkoh B, Hayes K, Kantarjian H, Jones D. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy. Cancer 106(8):1730-8, 2006. e-Pub 2006. PMID: 16532439.
213. Merzianu M, Medeiros LJ, Cortes J, Yin CC, Lin P, Jones D, Glassman A, Kantarjian H, Huh Y. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase - A clinicopathologic, cytogenetic, and molecular study of five cases. Am J Clin Pathol 124(5):807-14, 2005. e-Pub 2005. PMID: 16203287.
214. Yin CC, Lin P, Carney DA, Handy BC, Rassidakis GZ, Admirand JH, Keating MJ, Medeiros LJ. Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein. Am J Clin Pathol 123(4):594-602, 2005. e-Pub 2005. PMID: 15743747.
215. Yin CC, Glassman AB, Lin P, Valbuena JR, Jones D, Luthra R, Medeiros LJ. Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemia. Am J Clin Pathol 123(6):840-8, 2005. e-Pub 2005. PMID: 15899774.
216. Yin CC, Medeiros LJ, Glassman AB, Lin P. t(8;21)(q22;q22) in blastic phase of chronic myelogenous leukemia. Am J Clin Pathol 121(6):836-42, 2004. e-Pub 2004. PMID: 15198355.
217. Yin CC, Chapman J, Tawfik O. Invasive mucinous (colloid) adenocarcinoma of ectopic breast tissue in the vulva: a case report. Breast J 9(2):113-5, 2003. e-Pub 2003. PMID: 12603384.
218. Enders PJ*, Yin C*, Martini F, Evans PS, Propp N, Poccia F, Pauza CD (*These two authors contributed equally to this work). HIV-mediated gammadelta T cell depletion is specific for Vgamma2+ cells expressing the Jgamma1.2 segment. AIDS Res Hum Retroviruses 19(1):21-9, 2003. e-Pub 2003. PMID: 12581513.
219. Djavani M, Yin C, Lukashevich IS, Rodas J, Rai SK, Salvato MS. Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus. J Hum Virol 4(2):103-8, 2001. e-Pub 2001. PMID: 11437313.
220. Evans PS, Enders PJ, Yin C, Ruckwardt TJ, Malkovsky M, Pauza CD. In vitro stimulation with a non-peptidic alkylphosphate expands cells expressing Vgamma2-Jgamma1.2/Vdelta2 T-cell receptors. Immunol 104(1):19-27, 2001. e-Pub 2001. PMID: 11576216.
221. Djavani M, Yin C, Xia L, Lukashevich IS, Pauza CD, Salvato MS. Murine immune responses to mucosally delivered Salmonella expressing Lassa fever virus nucleoprotein. Vaccine 18(15):1543-54, 2000. e-Pub 2000. PMID: 10618553.
222. Yin C, Wu MS, Pauza CD, Salvato MS. High major histocompatibility complex-unrestricted lysis of simian immunodeficiency virus envelope-expressing cells predisposes macaques to rapid AIDS progression. J Virol 73(5):3692-701, 1999. e-Pub 1999. PMID: 10196261.
223. Yin C, Djavani M, Schenkel AR, Schmidt DS, Pauza CD, Salvato MS. Dissemination of lymphocytic choriomeningitis virus from the gastric mucosa requires G protein-coupled signaling. J Virol 72(11):8613-9, 1998. e-Pub 1998. PMID: 9765400.
224. Pauza CD, PWnd H, Yin C, McKechnie TS, Hinds SB, Salvato MS. The lymphocytosis-promoting agent pertussis toxin affects virus burden and lymphocyte distribution in the SIV-infected rhesus macaque. AIDS Res Hum Retroviruses 13(1):87-95, 1997. e-Pub 1997. PMID: 8989431.
225. PWnd H, Yin C, Salvato MS, Pauza CD. Pertussis toxin induces lymphocytosis in rhesus macaques. J Med Primatol 25(6):375-81, 1996. e-Pub 1996. PMID: 9210021.
226. Yin C, Zhang BX, Zheng J, Wu B. Comparison of the antitumor effect of tumor-infiltrating lymphocytes and tumor-involved lymph node lymphocytes. J Beijing Med Univ 27 (supple):23-5, 1995. e-Pub 1995.
227. Yin C, Zhang BX, Zheng J, Wu B. Combined antitumor effect of tumor-infiltrating lymphocytes and tumor necrosis factor alpha. Chinese J Pathol 24(3):162-4, 1995. e-Pub 1995. PMID: 7656383.
228. Zhang BX, Yin C, Tang Y, Wu B. The antitumor effect of tumor-infiltrating lymphocytes (TIL) being proliferated in vitro. Chinese J Pathol 21(2):79-81, 1992. e-Pub 1992.
229. Zhang BX, Tang Y, Yin C, Zheng J, Wu B. Experimental expansion and antitumor effect of LAK cells from cancer patient's peripheral blood. Chinese J Cancer 14(4):253-6, 1992. e-Pub 1992.
230. Zhang BX, Yin C, Tao J, Wu B. Observation on the phenotypic changes of tumor-infiltrating lymphocytes (TIL) during cultivation in vitro. Chinese J Pathol 21(5):281-3, 1992. e-Pub 1992.
231. Zhang BX, Tang Y, Zheng J, Yin C, Wang J, You J, Fang W, Wu B, Wang X, Gao R. Researches on the anti-autologous tumor effects of human cancer-killing cells in nude mice. Chinese J Cancer Res 4(4):30-2, 1992. e-Pub 1992.
232. Khan M, Kantarjian H, Yin CC, KiNardo CD, Naqvi K, Short N, Ravandi F, Borthakur G, KInopleva M, Andreeff M, Cortes J, Benton CB. Disease characteristics and patient outcomes in BCR-ABL-positive acute myeloid leukemia. Leuk Res.
233. Ishrak, R, Wu, X, Gajjela, C, Yin, CC, Reddy, R. A compact fiber-optic platform for label-free, chemically sensitive imaging.

Invited Articles

1. Li N, Chen M, Yin CC. Advances in molecular evaluation of myeloproliferative neoplasms. Semin Diagn Pathol 40(3):187-194, 2023. e-Pub 2023. PMID: 37087305.
2. Zuo Z, Li S, Xu J, You MJ, Khoury JD, Yin CC. Philadelphia-negative Myeloproliferative Neoplasms: Laboratory Workup in the Era of Next-generation Sequencing. Curr Hematol Malig Rep 14(5):376-385, 2019. e-Pub 2019. PMID: 31388824.
3. Yin CC, Luthra R. Molecular detection of t(11;14)(q13;q32) in mantle cell lymphoma. Methods Mol Biol 999:211-6, 2013. e-Pub 2013. PMID: 23666700.
4. Yin CC, Luthra R. Molecular detection of t(14;18)(q32;q21) in follicular lymphoma. Methods Mol Biol 999:203-9, 2013. e-Pub 2013. PMID: 23666699.
5. Yin CC, Luthra R. Detection of t(2;5)(p23;q35) in anaplastic large-cell lymphoma by long-range nested polymerase chain reaction assay. Methods Mol Biol 999:217-22, 2013. e-Pub 2013. PMID: 23666701.
6. Yin CC, Medeiros LJ, Bueso-Ramos CE. Recent advances in the diagnosis and classification of myeloid neoplasms - Comments on the 2008 WHO classification. Int J Lab Hematol 32(5):461-76, 2010. e-Pub 2010. PMID: 20626469.
7. Yin CC, Jones D, Cortes J, Kantarjian H, Medeiros LJ, Bueso-Ramos CE. Type B CBFb/MYH11 fusion transcript in de novo myeloid blast phase of chronic myeloid leukemia: Correlation with nuclear and cytoplasmic localization of the fusion protein. Clin Leukemia 2(4):257-60, 2008. e-Pub 2008.
8. Yin CC, Jones D. Molecular approaches towards characterization, monitoring and targeting of viral-associated hematological malignancies. Expert Rev Mol Diagn 6(6):831-41, 2006. e-Pub 2006. PMID: 17140370.

Review Articles

1. Wang L, Shi M, Sung AY, Yin CC, Bai Y, Chen M. Role of the bone marrow microenvironment in multiple myeloma: Impact of niches on drug resistance mechanisms. Semin Diagn Pathol 42(4):150916, 2025. e-Pub 2025. PMID: 40440932.
2. Rivera D, Naik U, Wang WJ, Cuglievan B, Yin CC, Chen L. Acute myeloid leukemia with inversion 16 and a novel PTPN11 mutation: A case report with literature review. Int J Lab Hematol 46(1):195-198, 2024. e-Pub 2024. PMID: 37872826.
3. Wu L, Xia M, Wang C, Yan H, Gong X, Yin CC. Expression, Function, and Significance of Non B Cell-Derived Immunoglobulin in Haematological System. Adv Exp Med Biol 1445:179-188, 2024. e-Pub 2024. PMID: 38967760.
4. Xie W, Medeiros LJ, Li S, Yin CC, Khoury JD, Xu J. PD-1/PD-L1 Pathway and its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large Cell Lymphomas. Curr Hematol Malig Rep 15(4):372-381, 2020. e-Pub 2020. PMID: 32394185.
5. Abaza Y, Yin CC, Bueso-Ramos CE, Wang SA, Verstovsek S. Primary autoimmune myelofibrosis: a case report and review of the literature. Int J Hematol 105(4):536-539, 2017. e-Pub 2017. PMID: 27830539.
6. Rich A, Sun J, Aldayel AS, Yin CC, Medeiros LJ, Konoplev S. Myelomastocytic Leukemia With Aberrant CD25 Expression: Case Report and Review of the Literature. Clin Lymphoma Myeloma Leuk 14(5):e173-7, 2014. e-Pub 2014. PMID: 25022599.
7. Lu G, Yin CC, Medeiros LJ, Abruzzo LV. Deletion 15q as the sole abnormality in acute myeloid leukemia: Report of three cases and review of the literature. Cancer Genet Cytogenet 188(2):118-23, 2009. e-Pub 2009. PMID: 19100517.
8. Yin CC, Medeiros LJ, Abruzzo LV, Jones D, Farhood AI, Thomazy VA. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient. Am J Clin Pathol 123(2):222-8, 2005. e-Pub 2005. PMID: 15842046.

Other Articles

1. Yin CC Role of MHC-unrestricted lysis in the pathogenesis and immunotherapy of human/simian immunodeficiency virus infection (Postdoctoral thesis), 1999.
2. Yin CC Targeted tumor immunotherapy using tumor-infiltrating lymphocytes (Master thesis), 1993.

Editorials

1. Yin CC. Detection and Molecular Monitoring of Minimal Residual Diseases in Acute Myeloid Leukemias. J Mol Biomark Diagn 3(2):e106, 2012.
2. Chen F, Yin CC. Preface to the Special Issue of Oncology. N Am J Med Sci 5(1):1, 2012.
3. Yin CC. Detection and Molecular Monitoring of Minimal Residual Disease in Chronic Myelogenous Leukemia. J Clin Exp Pathol 2(4):e110, 2012.

Abstracts

1. Tasnuva R, Bryan J, Routbort MJ, Garces S, Fang H, Sarami I, Toruner GA, Loghavi S, Quesada AE, Ok CY, Jelloul FZ, Yin CC, Kanagal-Shamanna R, Tang G, Daver N, CiNardo C, Ravandi F, Hagop KM, Medeiros LJ, Patel KP. RUNX1 fusion partners in AML: morphologic, molecular, and clinical insights beyond RUNX1::RUNX1T1. The115th USCAP Annual Meeting. e-Pub 2026.
2. Lossos I, Biral L, Thakkar D, Tan Y, Yorukoglu N, Kwong YL, Li S, Yin CC, Gulati R, Kikkeri N, Dave S, Chapman J. Genomic and transcriptomic landscape of extranodal marginal zone lymphoma. The 67th American Society of Hematology Annual Meeting, 2025. e-Pub 2025.
3. Toruner GA, Tang G, Agarwal NK, Loghavi S, Hu S, Kanagal-Shamanna R, Quesada A, Routbort M, Yin CC, Sarami I, Garces S, Fang H, Irogulescu B, Wei Q, Medeiros LJ, Patel K, Ok CY. Comparative analysis of targeted RNA-seq optical genome mapping for detecting clinically significant gene rearrangement in acute leukemia. The 16th Cancer Genomics Consortium Annual Meeting, 2025. e-Pub 2025.
4. Seeley EH, Bayshal A, Person MD, Pacheco CD, Ly C, Manshouri T, Yin CC, Veletic I. Sequential imaging and collagenase digest peptide identification from a multi-organ tissue microarray. The 73th American Society for Mass Spectrometry, 2025. e-Pub 2025.
5. Shuai W, Lin P, Hu S, Yin CC, Chen L, Wang W, Li S, Xu J, Elgela Ibrahim NG, Pan Z, You M, Patel KP, Vega F, Medeiros L, Hu Z. Clinicopathological Overlap Between Primary and Secondary Plasma Cell Leukemia: Implications for Lowering the Diagnostic Threshold for Circulating Plasma Cells. USCAP 2025, 2025. e-Pub 2025.
6. Kwon A, Palsgrove D, McLean A, Yin CC, Chen M. Collision tumors with incidental chronic lymphocytic leukemia/small lymphocytic lymphoma. Texas Society of Pathologists 104th Annual Meeting, 2025. e-Pub 2025.
7. Massarova L, bose P, Pemmaraju N, Borthakur G, Verstovsek S, Yin CC, Patel KP, Kantarjian H. Phase 2 study of pegylated interferon in patients with essential thrombocytopenia and polycythemia vera: final analysis focused on the two diseases. ASH 2024, 2024. e-Pub 2024.
8. Veletic I, Manshouri T, Yin CC, Pacheco CD, Ly CP, Dasdemir E, Cohen EN, Masarova L, Pemmaraju N, Bose P, Kantarjian HM, Estrov Z, Reville PK, Dunbar A, Abbas HA. Selective Pressures on Bone Marrow Fibrocytes Drive Fibrosis Progression in PMF. ASH 2024, 2024. e-Pub 2024.
9. Yin CC, Young PE, You MJ, Li S, Xu J, Medeiros LJ, Garces S. Ras-associated autoimmune leukoproliferative disorder (RALD): A patient with large cell transformation of mycosis fungoides, plasma cell neoplasm and persistent monocytosis. 22nd meeting of the European Association for Haematopathology, September 21-26, 2024, Dubrovnik, Croatia, 2024. e-Pub 2024.
10. Hu Z, Yin CC, Wang W, Wang S, You MJ. A Diagnostic Dilemma of A Patient with Skin Lesions and Marked Leukocytosis: Mixed Phenotype Acute Leukemia or BPDCN with Aberrant CD3 Expression?. 22nd meeting of the European Association for Haematopathology, September 21-26, 2024, Dubrovnik, Croatia, 2024. e-Pub 2024.
11. Garces S, Fang H, Leventaki V, Wang W, Medeiros LJ, Yin CC. A patient with Rosai-Dorfman disease (RDD), Ras-associated autoimmune leukoproliferative disorder (RALD) progressing to chronic myelomonocytic leukemia (CMML) and a clonal plasma cell proliferation. 22nd meeting of the European Association for Haematopathology, September 21-26, 2024, Dubrovnik, Croatia, 2024. e-Pub 2024.
12. E S, Yin CC, Hu S, Wei Q, Medeiros LJ, Wang W. Immunophenotypic and molecular landscapes of four types of acute leukemias derived from very early progenitors, 2024. e-Pub 2024.
13. Kim DH, Wang SA, Wang W, Tang G, Li S, Yin CC, Lin P, Konopleva M, You MJ, Wang X, Medeiros LJ, Xu J. Acute myeloid leukemia with mast cell differentiation is characterized with old age, interstitial mast cells, TP53 alterations, complex karyotype, and poor diagnosis, 2024. e-Pub 2024.
14. E S, Yin CC, Hu S, Wei Q, Medeiros LJ, Wang W. Immunophenotypic and molecular landscapes of four types of acute leukemias derived from very early progenitors, 2024. e-Pub 2024.
15. Le MK, Javavel M, Tholath LB, Hurst G, Zhao M, Nimmarkayalu M, He H, Liu X, Wang W, Hu S, Yin CC, Xu J, Li S Tang G, Tang Z, You MJ. Characterization and Identification of MYC Rearrangement Partners in Large B-Cell Lymphoma (LBCL) Cell Lines. 2024 DPLM Annual Research Symposium, 2024. e-Pub 2024.
16. Sheikh I, Alqahtani S, Yin CC, Connors JS, Ragoonanan D, Cuglievan B, McCall D, Gibson A, Nunez C, Roth M, Ohanian M, Borthakur G, Garcia MB. Avapritinib and decitabine in an adolescent with CBF SM-AML, 2024. e-Pub 2024.
17. He H, Yu F, Xu-Monette ZY, Dai E, Pham K, Yin CC, Yang Y, Hu S, Pham LV, You MJ. Targetable vulnerability of deregulated FOXM1/PLK1 signaling axis in diffuse large B cell lymphoma, 2024. e-Pub 2024.
18. Fang H, Beird HC, Wang SA, Ibrahim A, Tang Z, You MJ, Le N, Futreal PA, Hu S, Yin CC, Thakral B, Medeiros LJ, Wang W. Characterization of a Novel Type of Mature CD4-Positive T-cell Leukemia that Primarily Involves Peripheral Blood and Bone Marrow (platform presentation), 2024. e-Pub 2024.
19. Nahmod K, Wang S, Yin CC, Medeiros LJ, You MJ. CD4-CD8- peripheral T-cell lymphoma expressing TCR-γδ and rare cytotoxic markers, 2023. e-Pub 2023.
20. He H, Yu F, Nastoupil L, Xu-Monette Z, Pham K, Yin CC, Yang Y, Hu S, Young K, Pham L, You MJ. Dysregulated FOXM1/PLK1 signaling axis in diffuse large B cell lymphoma, 2023. e-Pub 2023.
21. E S, Yin CC, Fang H, Wang S, Tang Z, Xu J, Li S, Bueso-Ramos C, Wang W, Medeiros LJ, You MJ. Mature CD4-positive small T-cell leukemia/lymphoma, 2023. e-Pub 2023.
22. E S, You MJ, Zuo Z, Xu J, Li S, Tang Z, Wang S, Medeiros LJ, Yin CC. Refractory hepatosplenic T-cell lymphoma, alpha/beta type, with high tumor mutation burden and dominant EZH2 clone, 2023. e-Pub 2023.
23. Nirmalanantham P, Mo H, Xu J, Wang C, Vega F, Lin P, Yin CC, You MJ, Medeiros LJ, Li S. Systemic EBV-positive T-cell lymphoma, 2023. e-Pub 2023.
24. Nahmod K, Li S, Yin CC, Wang S, Lin P, You MJ, Medeiros LJ, Xu J. High grade hematopoietic neoplasm with features suggestive of T/NK-cell lymphoma, 2023. e-Pub 2023.
25. Yang Y, Wang Y, Yuan T, He H, Ye MT, Zhang Z, Xu J, Li S, Yin CC, Wang W, Quesada AE, Nastoupil LJ, Borthakur G, Zhang Y, You MJ. Role of PLEKHA8 in the Pathogenesis of T-cell Acute Lymphoblastic Leukemia, 2023. e-Pub 2023.
26. Aakash F, Thakral B, Wang SA, Tang G, Li S, Schlette E, Muzzafar T, Garces S, Yin CC, Xu J, Medeiros LJ, Konoplev S. Hepatosplenic T-cell lymphoma with concurrent cryptic T-cell prolymphocytic leukemia/lymphoma, 2023. e-Pub 2023.
27. Xu M, Thakkar D, Panse G, Yan J, Minden MD, Zandi S, Naresh KN, Czader M, Love C, Happ L, Koff J, Bettoney S, Jaye DL, Michael CC, Thompson MA, Soliman D, Louissaint A, Mckinney M, Sojitra P, Yin CC, Ondrejka S, Tse E, Dave S. Mutations in ASXL1 and/or TET2 Identify a Subset with Worse Outcomes in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasms (platform presentation), 2023. e-Pub 2023.
28. Tang Z, Tang G, Toruner GA, Yang S, Wang W, Fang H, El Achi H, Thakral B, Xu J, Yin CC, You MJ, Miranda R, Khoury JD, Medeiros LJ. Acquired 3q26.2 Aberrations/MECOM Rearrangement in Donor Cell Leukemia after Sex-Matched Stem Cell Transplant ‐ A Report of Two Cases, 2023. e-Pub 2023.
29. Kim DH, Jelloul F, Kanagal-Shamanna R, Yin CC, Zuo Z, Patel KP, Routbort MJ Vega F, Miranda RN, Medeiros LJ, Ok CY. Next-Generation Sequencing Identifies Approximately One Third of Mantle Cell Lymphoma Patients with Nuclear Factor-kappa B Pathway Mutations, 2023. e-Pub 2023.
30. Kim DH, Tang G, Lin P, Xu J, Wang SA, Qiu L, Yin CC, Wang W, Medeiros LJ, Li S. MYC and BCL6 Double Hit Lymphoma (DHL): A Clinicopathologic Study of 60 Cases in Comparison to BCL2-DHL and Diffuse Large B-cell Lymphoma (DLBCL) (platform presentation), 2023. e-Pub 2023.
31. E S, Medeiros LJ, Li S, Wang SA, Lin P, Wang W, Iyer SP, Malpica L, Yin CC, Tang G, Tang Z, You MJ, Xu J. Low CD25 Expression is Associated with Older Age and Poorer Prognosis in Patients with ALK+ Anaplastic Large Cell Lymphoma, 2023. e-Pub 2023.
32. Russell V, Younes S, Yin CC, Li S, Xu J. Elucidating the Genomic Landscape of Rosai-Dorfman Disease Using DNA and RNA Sequencing, 2023. e-Pub 2023.
33. Kositsky R, Ilja NN, Karjalainen-Lindsberg M, Johannes D, Panu K, Annika P, Love C, Hsi ED, Juskevicius R, EVans A, Czader M, Casulo C, Xu M, Paulson N, Koff J, McCall C, Pillai R, Chapman J, Amador C, Goswami R, Behdad A, Yin CC, Thacker E, Schejbel L, Thompson M, Tian S, Leppa SM. Nodular lymphocyte predominant Hodgkin lymphoma with splenic involvement is characterized by inflamed tumor microenvironment, high expression of checkpoint molecule gene-signature and adverse outcome, 2022. e-Pub 2022.
34. Jain P, Ok CY, Fetooh A, Kanagal-Shamanna R, Jelloul F, Hill HA, Floyd K, Loghavi S, Zuo Z, Yin CC, Routbort MJ, Tang G, Nair R, Ahmed S, Malpica L, Siddiqui A, Chen W, Oriabure O, Badillo M, Steiner R, Iyer SP, Lee HJ, Luthra R, Fowler N, Vega F, Flowers C, Medeiros LJ, Wang ML, Patel KP. Mutation spectrum, characteristics and impact of mutation profiling on prognosis, outcome and treatment responses in patients (pts) with mantle cell lymphoma, 2022. e-Pub 2022.
35. Chapman J, Taakkar D, Alderuccio JP, Kikkeri N, Ondrejka S, Hsi E, Xu M, Paulson N, Koff J, Jaye D, Cohen J, Norgaard P, Breinholt MF, Leeman-Neill R, Tushar D, Happ L, Love C, Zandi S, Naushad H, Mason E, Louissaint A, Kiat OC, Cheng CL, Pilai R, Pedersen M, Yin CC, Choi W, Au-Yeung R, Karjalainen-Lindsberg M, Chadburn A, Samo V, Montgomery N, McKinney M, Sojitra P, Evans A, Behdad A, Galvez C, Czader M, Jiong Y, Dave S, Lossos IS. Extranodal Marginal Zone Lymphomas Show Recurrent Mutations in DNA Repair Genes, Cancer-Associated Proliferative Signaling and NOTCH1 Signaling Pathways, Regardless of Anatomic Site, 2022. e-Pub 2022.
36. Wang L, Thompson M, Mason EF, Yin CC, Yerrapotu N, Czader MB. Age-related genomic landscape of T lymphoblastic leukemia/lymphoma, 2022. e-Pub 2022.
37. Nwogbo OV, Hao S, Hu S, Li S, Xu J, Yin CC, Bueso-Ramos C Tang G, Medeiros LJ, Lin P. Prognostic Impact of 8q24/MYC Rearrangement in Myeloma in the Era of Novel Therapy, 2022. e-Pub 2022.
38. Hurst G, He H, Yin CC, Wang W, Yang Y, Liu X, Nimmakayalu M, You MJ. Characterization of Large B-Cell Lymphoma Cell Lines, 2022. e-Pub 2022.
39. Hu Z, Yin CC, Wang WJ, Lin P, Glass WF, Medeiros LJ, You MJ. AL Amyloidosis with Associated Low-Grade B-Cell Lymphoma: A Report of 18 Cases, 2022. e-Pub 2022.
40. Tang Z, Wang W, Toruner GA, Yang S, Fang H, Xu J, Thakral B, Zhao M, Ayoub E, Issa GC, Yin CC, You MJ, Khoury JD, Medeiros LJ, Tang G. MECOM Rearrangement by Pericentric Inversion 3 Presents a Huge Diagnostic Challenge, 2022. e-Pub 2022.
41. Tang Z, Zhao M, Tang G, Wang W, Hu S, Fang H, Sfamenos S, Toruner GA, Yin CC, Gu J, You MJ, Wang SA, Khoury JD, Medeiros LJ. Targeting the MECOM Rearrangement-Driving Chromosomal Complexities: Diagnostic Approaches, 2022. e-Pub 2022.
42. Au-Yeung RKH, Choi W, Wong A, xxx, Li S, Xu J, Yin CC, Naresh KN, Love C, Tse E. ALK-Negative Anaplastic Large Cell Lymphomas Encompass Distinct Subgroups Including an ALK-Positive-like Subgroup with Favorable Prognosis, 2021. e-Pub 2021.
43. Yeung RA, Russell V, Choi W, Yin CC, Dave S. ALK-negative ALCLs encompass distinct subgroups including an ALK-positive like subgroup with favorable prognosis, 2021. e-Pub 2021.
44. Mohamed SF, Khan M, Quesada AE, Ma J, Lin P, Yin CC, Sasaki K, Borthakur G, Pemmaraju N, Bashir Q, Qazilbash MH, Kaufman GP, Becnel M. Disease Characteristics of Multiple Myeloma Involving BRAF Mutations, 2021. e-Pub 2021.
45. Ok CY, Jain P, Floyd K, Loghavi S, Kanagal-Shamanna R, Zuo Z, Yin CC, Routbort MJ, Luthra R, Wang ML, Medeiros LJ, Patel KP. EndLymphoma Assay v1: Enabling NGS-Based Comprehensive Routine Molecular Profiling of Mantle cell lymphoma in Routine Clinical Care, 2021. e-Pub 2021.
46. Yin CC, Lin P, Li S, Xu J, You MJ, Bueso-Ramos CE, Medeiros LJ, Wang SA. Relapsed B-ALL with aberrant MPO expression following CAR T-cell therapy, 2021. e-Pub 2021.
47. Khanlari M, Xu J, Lin P, You MJ, Yin CC, Qiu L, Medeiros LJ, Li S. Triple hit high grade B-cell Lymphoma with blastoid morphology, 2021. e-Pub 2021.
48. Khanlari M, Li S, Medeiros LJ, Iyer S, Yin CC, Lin P, Tang G, Konoplev SN, Miranda RN, Xu J. Small cell/lymphohistiocytic morphology is associated with CD8 positivity, retained T cell markers, a trend of decreased PD-L1 expression, but not outcome in adults with ALK+ ALCL, 2021. e-Pub 2021.
49. Shuai W, Chen W, Floyd K, Routbort M, San Lucas F, Kanagal-Shamanna R, Zuo Z, Loghavi S, Ok CY, Yin CC, Luthra R, Medeiros LJ, Patel KP. Ultra-rapid reporting of TP53 mutation in myeloid neoplasms by using next generation sequencing, 2021. e-Pub 2021.
50. Nezami B, Toruner G, Routbort M, San Lucas F, Yang R, Seyedjafari R, Chen H, Rashid A, Loghavi S, Roy S, Kanagal-Shamanna R, Yin CC, Zuo Z, Ok CY, Tang Z, Medeiros LJ, Luthra R, Patel KP. Clinical Utility of NGS-based gene fusion testing in solid tumors, 2021. e-Pub 2021.
51. Qiu L, Kharlari M, Li S, Tang G, Yin CC, Wang S, Iyer S, You MJ, Konoplev SN, Miranda RN, Medeiros LJ, Xu J. Leukemic ALK-negative ALCL is characterized by thrombocytopenia, bone marrow involvement, CD7 positivity, complex karyotype, and a poor prognosis, 2021. e-Pub 2021.
52. Yang Y, Bueso-Ramos C, Yin CC, Zhang H, Miranda RN, Borthakur G, Medeiros LJ, Calin GA, Han X, You MJ. Down-regulation of miR-150 and its inhibition on the growth of T cell acute lymphoblastic leukemia, 2021. e-Pub 2021.
53. Wen S, Chen W, Floyd K, Routbort M, Lucas AS, Kanagal-Shamanna R, Zuo Z, Loghavi S, Ok C, Yin CC, Luthra R, Medeiros LJ, Patel KP. Ultra-Rapid Reporting of TP53 Mutation by Next Generation Sequencing, 2021. e-Pub 2021.
54. Qiu L, Khanlari M, Li S, Tang G, Yin CC, Wang SA, Iyer S, You MJ, Konoplev SN, Miranda RN, Medeiros LJ, Xu J. Leukemic ALK-negative ALCL is Characterized by Thrombocytopenia, Bone Marrow Involvement, CD7 Positivity, Complex Karyotype, and a Poor Prognosis, 2021. e-Pub 2021.
55. Nezami BG, Torruner G, Routbort MJ, Lucas AS, Alvarez H, Yang R, Seyedjafari R, Chen H, Rashid A, Loghavi S, Roy SC, Kanagal-Shamanna R, Yin CC, Zuo Z, Ok CY, Tang Z, Medeiros LJ, Luthra R, Patel KP. Clinical Utility of NGS-Based Gene Fusion Testing in Solid Tumors, 2021. e-Pub 2021.
56. Khanlari M, Lin P, Xu J, You MJ, Tang G, Yin CC, Qiu L, Bueso-Ramos CE, Medeiros LJ, Li S. Blastoid Large B Cell Lymphoma with Primary Bone Marrow Presentation: A Diagnostic Challenge, 2021. e-Pub 2021.
57. Jain P, Yao Y, Zhao S, Liu Y, Hill HA, Che Y, Li Y, Jordan A, MdIntosh J, Lee HJ, Steiner R, Samaniego F, Westin J, Nastoupil L, Nair R, Ahmed S, Ok CY, Kanagal-Shamanna R, Oriabure O, Xu G, Chen W, Moghrabi OB, McClain C, Badillo M, Thirumurthi S, Santos D, Yin CC, Li S, Tang G, Vega F, Neelapu S, Flowers C, Wang L, Wang ML. Combination of ibrutinib with rituximab (IR) in previously untreated elderly patients with mantle cell lymphoma (MCL) – a phase II clinical trial, 2020. e-Pub 2020.
58. Jain P, Yao Y, Jiang C, Liu Y, Hill HA, Che Y, Li Y, Lee HJ, Steiner R, Samaniego F, Nair R, Ahmed S, OK CY, Kanagal-Shamanna R, Oriabure O, Chen W, Xu G, Khoury SCE, Badillo M, Yin CC, Li S, Tang G, Vega F, Flowers C, Wang L, Wang ML. Phase II Trial of ibrutinib in previously untreated high risk smoldering mantle cell lymphoma, 2020. e-Pub 2020.
59. Jain P, Zhang S, Kanagal-Shamanna R, Navsaria L, Ok CY, Tang G, Yin CC, Badillo M, Chen W, Oriabure O, Lee HJ, Westin J, Nastoupil L, Moghrabi O, Che Y, Samaniego F, Ahmed S, Nair R, Li S, Vega F, Flowers C, Wang L, Wang ML. Outcomes of acalabrutinib failures in relapsed mantle cell lymphoma, 2020. e-Pub 2020.
60. Kanagal-Shamanna R, Kantarjian H, Khoury J, Takahashi K, Montalban-Bravo G, Short NJ, Yin CC, Patel KP, Loghavi S, DiNardo C, Ravandi F, Konopleva M, Jain N, Garcia-Manero G, Daver N, Kadia T, O'Brien S, Luthra R, Jabbour E. Distinct Prognostic Effects of TP53 Mutations in Newly Diagnosed Versus Relapsed/Refractory (R-R) Patients (pts) with B-Acute Lymphoblastic Leukemia (ALL) Treated with Mini-HCVD-Inotuzumab Ozogamicin with or without Blinatumomab Regimens (selected as "Top-25 abstract), 2020. e-Pub 2020.
61. Wang ML, Jain P, Yao Y, Liu Y, Zhao S, Hill HA, Liu Y, Moghrabi OB, Lee HJ, Samaniego F, Westin J, Nastoupil L, Kanagal-Shamanna R, OK CY, Chen W, Oriabure O, Che Y, Li Y, Feng L, Gonzalez GN, Xu G, Wagner-Bartak N, Thirumurthi S, Santos D, Tang G, Vega F, Yin CC, Avellaneda M, Badillo M, Flowers C, Wang L. Ibrutinib plus rituximab (IR) followed by short course R-HyperCVAD/MTX in patients (age ≤ 65 years) with previously untreated mantle cell lymphoma – phase-II WINDOW-1 clinical trial, 2020. e-Pub 2020.
62. Jain P, Tang G, Yin CC, OK CY, Navsaria L, Badillo M, Chen W, Onyeka Oriabure O, Gonzalez GN, Westin J, Nastoupil L, Sairah Ahmed S, Nair R, Thirumurthi S, Li S, Kanagal-Shamanna R, Vega F, Flowers C, Wang ML. Complex karyotype is a significant predictor for worst outcomes in patients with mantle cell lymphoma (MCL) treated with BTK inhibitors – comprehensive analysis of 396 patients, 2020. e-Pub 2020.
63. Rafei H, Yin CC, Jabbour EJ. Impact of Cytogenetic Abnormalities (CA) on Outcome of Patients (Pts) with Relapsed/Refractory (R-R) Acute Lymphoblastic Leukemia (ALL) Treated with Inotuzumab Ozogamicin (INO) in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) with or without Blinatumomab: Results from a Phase 2 Study, 2020. e-Pub 2020.
64. Yang RK, Tang Z, Tang G, Toruner GA, Yin CC, Wang W, Hu S, Zuo Z, Patel KP, Khoury JD, Medeiros LJ. Atypical CBFB FISH Signal Patterns Warrant Further Investigation for a True CBFB Rearrangement: an Analysis of 2425 CBFB FISH Tests, 2020. e-Pub 2020.
65. Khanlari M, Li S, Miranda RN, Iyer S, Yin CC, Lin P, Tang G, Konoplev SN, Medeiros LJ, Xu J. Small cell/lymphohistiocytic morphology is associated with CD8 positivity, retained T cell markers, a trend of decreased PD-L1 expression, but not outcome in adults with ALK+ ALCL, 2020. e-Pub 2020.
66. Khanlari M, Loghavi S, Wang SA, El Hussain S, Tashakori M, Bueso-Ramose CE, Yin CC, Kanagal-Shamanna R, Khoury JD, Medeiros LJ, Patel KP, Popat UR, Konoplev S. The Significance of Bone Marrow Morphologic Features for Surveillance of Patients with Myelofibrosis Following Molecular Clearance After Stem Cell Transplant, 2020. e-Pub 2020.
67. Khanlari M, Li S, Medeiros LJ, Yin CC, Lin P, Tang G, Iyer S, Konoplev SN, Miranda RN, Xu J. Small Cell/Lymphohistiocytic Morphology is Associated with CD8 Positivity and Retained T Cell Markers but not Outcome in Adults with ALK+ ALCL, 2020. e-Pub 2020.
68. Veletic I, Yin CC, Verstovsek S. Spatial Distribution of Bone Marrow T-Cells and Antigen Presenting Cells Correlates with Inflammation and Disease Burden in Patients with Primary Myelofibrosis, 2019. e-Pub 2019.
69. Shen J, Li S, Yin CC, Wang S, Lin P, Jorgensen J, Tang G, Hu S, Medeiros LJ, Xu J. CD8 Expression in Anaplastic Large Cell Lymphoma Identifies a Subgroup with Advanced Stage, Non-common Morphology, Unique Phenotype, and Poorer Outcome, 2019. e-Pub 2019.
70. Pemmaraju N, Kantarjian HM, Khoury JD, Loghavi S, O'Brien S, Cortes JE, Garcia-Manero G, Jabbour E, Verstovsek S, Jain N, Duvic M, Aung P, Yin CC, Konoplev S, Patel KP, Pierce SA, Beird H, Qazilbash MH, Konopleva MY. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Commonly Presents in the Setting of Prior or Concomitant Hematologic Malignancies (PCHM): Patient Characteristics and Outcomes in the Rapidly Evolving Modern Targeted Therapy Era, 2019. e-Pub 2019.
71. Lyapichey K, Medeiros LJ, Li S, Yin CC, Tang G, You MJ, Konoplev SN, Bueso-Ramos C, Miranda R, Xu J. MYC Expression in Systemic Anaplastic Large Cell Lymphoma: Clinicopatbologic and Prognostic Features of 70 Patients, 2019. e-Pub 2019.
72. Garces S, Piubelli MLM, Siquiera SAC, Sriganeshan V, Medina AM, Castellano-Sanchez A, Poppiti R, Khoury JD, Li S, Xu J, Saluja K, Bhattacharjee MB, Medeiros LJ, Yin CC. Cyclin D1 protein is overexpressed in Rosai-Dorfman disease, 2019. e-Pub 2019.
73. Jain P, Zhao S, Kanagal-Shamanna R, Navsaria L, Hill HA, Nomie K, Misra A, Jiang C, Yao Y, Zhang L, Nastoupil L, Hagemeister F, Westin J, Nair R, Steiner R, Oriabure O, Chen W, Tang G, Yin CC, Patel KP, Romaguer J, Fowler N, Wang L, Wang ML. Non-Bcl2 mutations are predominant in patients (pts) with venetoclax resistant mantle cell lymphoma (MCL) – response and clinical outcomes in ultra-refractory MCL, 2019. e-Pub 2019.
74. Xie W, Sakhdari A, Loghavi S, Kanagal-Shamanna R, Zuo Z, Yin CC, Routbort MJ, Patel KP, Luthra R, Medeiros LJ, Ok CY. The Result of 122 Consecutive NGS-based Analysis of T-Lymphoblastic Leukemia/Lymphoma and Early T-cell Precursor Leukemia (ETP), 2019. e-Pub 2019.
75. Tang Z, Tang G, Toruner GA, Yang S, Yin CC, Khoury J, Miranda R, Medeiros LJ. BCR/ABL1 Fusion by Chromosomal Insertion: an Analysis of 15 Cases, 2019. e-Pub 2019.
76. Ok CY, Chen Z, Loghavi S, Kanagal-Shamanna R, Zuo Z, Yin CC, Routbort M, Patel KP, Luthra R, Medeiros LJ, Wang S. Prevalence and Clinical Implication of Splicing Factor Gene Mutation in Patients with Primary Myelofibrosis, 2019. e-Pub 2019.
77. Richard-Carpentier G, Kantarjian HM, Tang G, Yin CC, Khoury J, Issa G, Jain N, Ravandi F, Short NJ, DiNardo CD, Takahashi K, Ohanian M, Borthakur G, Konopleva MY, Daver NG, Estrov Z, Alvarado Y, Ferrajoli A, Kadia T, Garcia-Manero G, Verstovsek S, Garris R, Cortes J, O'Brien S, Jabbour E. Characteristics and Clinical Outcomes of Patients with Acute Lymphoblastic Leukemia with KMT2A (MLL) rearrangement, 2019. e-Pub 2019.
78. Jelloul FZ, Wang P, Yang R, Kanagal-Shamanna R, Ok CY, Loghavi S, Routbort MJ, Zuo Z, Yin CC, Floyd K, Wierda W, Luthra R, Medeiros LJ, Patel KP. Non-coding NOTCH1 mutations in chronic lymphocytic leukemia, 2019. e-Pub 2019.
79. Hidalgo-Lopez JE, Bueso-Ramos C, Khoury JD, Yin CC, Miranda RN, Huh Y, Thakral B, Wang WB, Medeiros LJ, Kanagal-Shamanna R. Metastatic Angiosarcoma Initially Diagnosed In the Bone Marrow, 2019. e-Pub 2019.
80. Wang ML, Jain P, Lee HJ, Hagemeister F, Samaniego F, Westin J, Nastoupil L, Chen W, Nomie K, Zhao S, Moghrabi OB, Zhao S, Kanagal-Shamanna R, Ok CY, Oriabure O, Gonzalez GN, Jung D, Navsaria L, Zhang L, Jiang C, Yao Y, Xu G, Wagner-Bartak N, Thirumurthi S, Santos D, Tang G, Patel KP, Yin CC, Avellaneda M, Badillo M, Fayad L, Neelapu S, Fowler N, Wang L, Romaguera J. Frontline treatment with ibrutinib plus rituximab (IR) followed by short course R-HyperCVAD/MTX is extremely potent and safe in patients (age ≤ 65 years) with mantle cell lymphoma (MCL) – results of phase-II WINDOW-1 clinical trial, 2019. e-Pub 2019.
81. Li X, Kositsky R, Reddy A, Yin CC, Dave S. Whole exome and transcriptome sequencing in 1042 cases reveals distinct clinically relevant genetic subgroups of Follicular Lymphoma. Blood 134(Suppl 1):19, 2019. e-Pub 2019.
82. Konoplev S, Thakral B, Yin CC, Li S, Lin P. Aggressive NK-cell leukemia, 2019. e-Pub 2019.
83. Xu J, Wang S Wang L, Tang G, Lin P, Yin CC, Medeiros LJ, Li S. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma-Like Mantle Cell Lymphoma, 2019. e-Pub 2019.
84. Xu J, Saksema A, Wang L, Yin CC, Wang SA, Hu Z, Lin P, Tang G, Medeiros LJ, Li S. Characterization of SOX11-negative mantle cell lymphoma: Clinicopathologic and prognostic features of 53 patients, 2018. e-Pub 2018.
85. He J, Lu X, Li S, Hu S, Wang W, Yin CC, Lin P. Multiple myeloma with t(14;16) MAF-IGH is associated with other high risk Genetic features, 2018. e-Pub 2018.
86. Pemmaraju N, Kantarjian HM, Khoury JD, O'Brien SM, Cortes JE, Garcia-Manero G, Jabbour E, Jain N, Aung P, Yin CC, Konoplev SN, Patel KP, Pierce S, Zhou L, Konopleva M. Outcomes in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Longer-Term Follow-Up Demonstrates Poor Outcomes in Patients with Skin-Only Presentation 132:3980, 2018. e-Pub 2018.
87. Garces S, Yin CC, Patel KP, Khoury JD, Manning JT, Li S, Xue J, Medeiros LJ. Rosai-Dorfman disease co-existing with lymphoma in the same lymph node: a localized histiocytic proliferation with MAPK/ERK pathway-induced cyclin D1 upregulation, 2018. e-Pub 2018.
88. Ruiz-Cordero R, Floyd K, Loghavi S, Kanagal-Shamanna R, Yin CC, Zuo Z, Routbort MJ, Luthra R, Kantarjian HM, Medeiros LJ, Patel KP, Ok CY. PTPN11 mutation is uncommon in acute myeloid leukemia, but associated with a complex karyotype, co-mutations in KRAS or NRAS and poor prognosis, 2018. e-Pub 2018.
89. Shen J, Li S, Lin P, Yin CC, Tang G, Jorgensen JL, Wang SA, Xue J. CD8-positive anaplastic large cell lymphoma, 2018. e-Pub 2018.
90. Garces S, Huang W, Li S, Hu S, Wang W, Yin CC, Xu J, Medeiros LJ, Lin P. Clinicopathologic and immunophenotypic features of MYD88 L265P– positive Lymphoplasmacytic lymphoma/Waldenström Macroglobulinemia: A study of 30 cases, 2018. e-Pub 2018.
91. Manshouri T, Veletic I, Yin CC, Chen L, Bose JE, Zhang Y, Verstovsek S, Estrov Z. Bone Marrow Fibrocytes Overexpress Gli1 Oncogenic Transcription Factor in Primary Myelofibrosis, 2018. e-Pub 2018.
92. Verstovsek S, Mesa R, Pozdnyakova O, Hasserjian R, Mascarenhas J, Foltz L, Ritchie E, Silver R, Kermyanskaya M, Veletic I, Manshouri T, Yin CC, Estrov Z, Vandenblink B, Gupta R, Gotlib J. PRM-151 in myelofibrosis: Efficacy and safety in an open label extension study (oral presentation), 2018. e-Pub 2018.
93. Hu B, Patel K, Chen H, Wang X, Luthra R, Routbort M, Kanagal-Shamanna R, Medeiros LJ, Yin CC, Zuo Z, Ok C, Loghavi S, Thompson PA, Keating MJ, Burger JA, Jain N, Ferrajoli A, Bose P, Estrov Z, Wierda WG. ATM mutation and unmutated IGHV status are the strongest predictors of time to first treatment: An analysis of multigene profiling for 384 treatment-naive chronic lymphocytic leukemia (CLL) patients, 2018. e-Pub 2018.
94. Sakhdari A, Logahvi S, Kanagal-Shamanna R, Yin CC, Zuo Z, Routbort MJ, Patel KP, Luthra R, Medeiros LJ, Ok CY. Incorporation of TP53 Gene Mutation in Genetic Risk Stratification of Adult T-Cell Lymphoblastic Leukemia (T-ALL) Better Predicts Survival, 2018. e-Pub 2018.
95. Ruiz-Cordero R, Chen W, Floyd K, Rodriguez S, Galbincea J, Barkoh B, Routbort M, Luthra R, Singh R, Hatfield D, Kanagal-Shamanna R, Yin CC, Zuo Z, Loghavi S, Ok C, Medeiros LJ, Patel KP. Breaking the turnaround time barrier in next generation sequencing-based clinical mutation profiling using an integrated workflow and informatics approach, 2017. e-Pub 2017.
96. Yin CC, Li J, Li S, Xu J, Li N, Jorgensen JL, Lin P, Bueso-Ramos CE, Medeiros LJ. Philadelphia chromosome-positive acute leukemia with an early T-cell precursor immunophenotype, 2017. e-Pub 2017.
97. Saksena A, Li J, Yin CC, Lin P, Zhou J, Miranda R, Li S. CD23-positive mantle cell lymphoma: a linicopathologic analysis of 59 cases. Mod Pathol, 2017. e-Pub 2017.
98. Li S, Tang G, Wang SA, Konoplev S, Yin CC, Xu J, Medeiros LJ, Lin P. B-lymphoblastic leukemia with CRLF2 rearrangement and JAK2 mutation, 2017. e-Pub 2017.
99. Saksena A, Li J, Yin CC, Lin P, Zhou J, Miranda R, Li S. CD23-positive mantle cell lymphoma: a clinicopathologic analysis of 59 cases. Mod Pathol, 2017. e-Pub 2017.
100. Kanagal-Shammana R, Luthra R, Routbort MJ, Singh R, Floyd K, Abraham R, Hain S, Yin CC, Zuo Z, Ok C, Loghavi S, Medeiros LJ, Patel KP. Multi-platform-based comprehensive molecular analysis of hematological malignancies for somatic mutations, copy number changes and translocations in routine clinical testing, 2017. e-Pub 2017.
101. Yin CC, Khour JD, Xu J, Lin P, You MJ, Muzzafar T, Bueso-Ramos CE, Medeiros LJ, Li S. Acute myeloid leukemia with clonal evolution upon progression, 2017. e-Pub 2017.
102. Saksena A, Li J, Yin CC, Lin P, Zhou J, Miranda R, Li S. CD23-positive mantle cell lymphoma: a linicopathologic analysis of 59 cases. Mod Pathol, 2017. e-Pub 2017.
103. Yin CC, Patel KP, Zuo Z, Wang SA, Li S, Medeiros LJ, Bueso-Ramos CE. Acute promyelocytic leukemia with novel IRF2BP2-RARA fusion, 2017. e-Pub 2017.
104. Xu J, Saksena A, Zhou J, Li J, Yin CC, Tang G, Medeiros LJ, Li S. CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 28 cases, 2017. e-Pub 2017.
105. Ok CY, Singh R, Luthra R, Hatfield D, Floyd K, Loghavi S, Kanagal-Shamanna R, Zuo Z, Yin CC, Routbort MJ, Kantarjian HM, Medeiros LJ, Patel KP. EndLeukemia Assay v1: Enabling NGS-based comprehensive routine molecular profiling of leukemias in routine clinical care, 2017. e-Pub 2017.
106. Xu J, Medeiros LJ, Yin CC, Tang G, Lin P, Li S. Triple-hit blastoid mantle cell lymphoma presenting like acute leukemia, 2017. e-Pub 2017.
107. Pemmaraju N, Kantarjian H, Khoury J, O'Brien S, Cortes J, Garcia-Manero G, Jabbour E, Jain N, Alvarado Y, Duvic M, Aung P, Qazillbash M, Yin CC, Konoplev S, Patel KP, PIerce S, Brandt M, Konopleva M. Long-term outcomes in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), 2017. e-Pub 2017.
108. Garces S, Medeiros LJ, Patel KP, Li S, Pina-Oviedo S, Li J, Khoury JD, Yin CC. Recurrent KRAS and MAP2K1 mutations detected in Rosai-Dorfman disease by next-generation sequencing, 2017. e-Pub 2017.
109. Saksena A, Li J, Yin CC, Lin P, Zhou J, Miranda R, Li S. CD23-positive mantle cell lymphoma: a linicopathologic analysis of 59 cases. Mod Pathol, 2017. e-Pub 2017.
110. Saksena A, Li J, Yin CC, Lin P, Zhou J, Miranda R, Li S. CD23-positive mantle cell lymphoma: a linicopathologic analysis of 59 cases. Mod Pathol, 2017. e-Pub 2017.
111. Yin CC, Li N, Li S, Zuo Z, Li J, Young KH, Medeiros LJ, Bueso-Ramos CE. Chronic myeloid leukemia, preleukemic phase, with t(9;22)(q34;q11.2)/BCR-ABL1, 2017. e-Pub 2017.
112. Veletic I, Manshouri T, Yin CC, Newberry K, Verstovsek S, Estrov Z. Neoplastic monocyte-derived osteoclasts are highly proliferative, but sub-functional in MPN-associated myelofibrosis, 2017. e-Pub 2017.
113. Hu Z, Konoplev S, Li S, Yin CC, Lopez JEH, Bueso-Ramos CE. Primary myelofibrosis presenting with marked monocytosis mimicking chronic myelomonocytic leukemia at initial presentation, 2017. e-Pub 2017.
114. Liu H, Yin CC, Wang SA, Xu J, Medeiros LJ, Tang G. Clinicaopathologic features of adult myeloid neoplasm with t(16;21), 2017. e-Pub 2017.
115. Gur D, Loghavi S, Routbort M, Garcia-Manero G, Yin CC, Li S, Medeiros LJ, Khoury JD. JAK2 p.V617F mutation is common in chronic myelomonocytic leukemia with fibrosis, 2017. e-Pub 2017.
116. Hu B, Patel K, Wang X, Chen H, Thompson PA, Keating MJ, Birger JA, Jain N, Ferrajoli A, Bose P, Estrov Z, Luthra R, Kanagal-Shamanna R, Medeiros LJ, Yin CC, Zuo Z, Ok CY, LOghave S, Wierda WG. Standardized targeted sequencing of 29 genes with recurrent mutations in chronic lymphocytic leukemia (CLL) helps to better define clinical correlates and genomic hotspots, 2017. e-Pub 2017.
117. Li S, Xu J, Wang W, Konoplev S, Medeiros LJ, Bueso-Ramos CE, Yin CC. Chronic myeloid leukemia in myeloid blast phase with inv16(p13.1q22)/CBFB-MYH11, 2017. e-Pub 2017.
118. Li S, Xu J, Yin CC, Khoury J, Medeiros LJ, Bueso-Ramos CE, Lin P. Refractory myelodysplastic syndrome with JAK2 mutation, 2017. e-Pub 2017.
119. Kurt H, Yin CC, Bueso-Ramos CE, Wang SA. Myelodysplastic syndrome with myelofibrosis, 2017. e-Pub 2017.
120. Yin CC. Clinical applications of immunoglobulin expression in acute myeloid leukemia, 2016. e-Pub 2016.
121. Yin CC. Clinical significance of CD5 expression in B-cell lymphomas, 2016. e-Pub 2016.
122. Issa GC, Kantarjian HM, Yin CC, Ravandi F, Garcia-Manero G, Thomas DA, Cortes JE, Short NJ, Sasaki K, Pierce S, Verstovsek S, Kadia TM, Borthakur G, O'Brien SM, Jabbour E. Prognostic impact of pre-treatment cytogenetics in adult acute lymphoblastic leukemia, 2016. e-Pub 2016.
123. Hodjat P, Priyanka P, Ghosh K, Thakral B, Patel KP, Routbort M, Kanagal-Shamanna R, Yin CC, Zuo Z, Luthra R, Muzzafar TM. Mutation analysis in 35 cases of newly diagnosed therapy related acute myeloid leukemia by next generation sequencing (NGS): a clinico-pathologic correlation, 2016. e-Pub 2016.
124. Xu J, Saksena A, Desai P, Lin P, Yin CC, Tang G, You J, Medeiros LJ, Li S. CD30 Expression and Its Prognostic Significance in De Novo Diffuse Large B Cell Lymphoma Treated with Rituximab-EPOCH, 2016. e-Pub 2016.
125. Pina-Oviedo S, Medeiros LJ, Li S, Alayed K, Yin CC. Langerhans cell histiocytosis in patients with concurrent lymphoma: a reactive Langerhans cell histiocytosis in patients with concurrent lymphoma: a reactive process without evidence of BRAF mutation, 2016. e-Pub 2016.
126. Hodjat P, Priyanka P, Ghosh K, Thakral B, Patel KP, Routbort M, Kanagal-Shamanna R, Yin CC, Zuo Z, Luthra R, Muzzafar TM. Mutation analysis in 45 cases of newly diagnosed acute myeloid leukemia with recurrent cytogenetic abnormalities by next generation sequencing: a clinico-pathologic correlation, 2016. e-Pub 2016.
127. Ghosh K, Hidjat P, Priyanka P, Thakral B, Patel KP, Routbort M, Kanagal-Shamanna R, Yin CC, Zuo Z, Luthra R, Muzzafar T. Mutation analysis in 117 cases of newly diagnosed myelodysplastic syndrome: IPSS-R high and very high risk by next generation sequencing: a clinico-pathologic correlation, 2016. e-Pub 2016.
128. Hodjat P, Priyanka P, Ghosh K, Thakral B, Patel KP, Routbort M, Kanagal-Shamanna R, Yin CC, Zuo Z, Luthra R, Muzzafar TM. Mutation analysis in 50 cases of newly diagnosed acute myeloid leukemia arising from myelodysplastic syndrome by next generation sequencing: a clinico-pathologic correlation, 2016. e-Pub 2016.
129. Hodjat P, Priyanka P, Ghosh K, Thakral B, Patel KP, Routbort M, Kanagal-Shamanna R, Yin CC, Zuo Z, Luthra R, Muzzafar TM. Mutation analysis in 8 cases of newly diagnosed acute myeloid leukemia arising from myeloproliferative neoplasms by next generation sequencing: a clinico-pathologic correlation, 2016. e-Pub 2016.
130. Hodjat P, Priyanka P, Ghosh K, Thakral B, Patel KP, Routbort M, Kanagal-Shamanna R, Yin CC, Zuo Z, Luthra R, Muzzafar TM. Mutation analysis in 122 cases of newly diagnosed normal karyotype acute myeloid leukemia by next generation sequencing: a clinico-pathologic correlation, 2016. e-Pub 2016.
131. Thakral B, Desai P, Lin P, Yin CC, Tang G, Hu S, Khoury JD, Medeiros LJ, Li S. Prognostic significance of CD5 expression in diffuse large B-cell lymphoma in patients treated with Rituximab-EPOCH, 2016. e-Pub 2016.
132. Yin CC, Li S, Xu J, Lin P, Medeiros LJ, Abruzzo LV. Mantle cell lymphoma, blastoid variant, arising from classical mantle cell lymphoma, 2016. e-Pub 2016.
133. Saksena A, Miao Y, Lin P, Wang M, Yin CC, Li J, Medeiros LJ, Li S. CD5-negative mantle cell lymphoma: clinicopathologic correlations and outcome in 58 cases, 2016. e-Pub 2016.
134. Quesada AE, Hu Z, Routbort MJ, Patel KP, Luthra R, Loghavi S, Zuo Z, Yin CC, Kanagal-Shamanna R, Wang SA, Jorgensen J, Medeiros LJ, Ok CY. Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing, 2016. e-Pub 2016.
135. Masarova L, Yin CC, Cortes JE, Konopleva M, Borthakur G, Newberry KJ, Kantarjian HM, Bueso-Ramos CE, Verstovsek S. Histomorphological responses after therapy with pegylated interferon alpha-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV), 2016. e-Pub 2016.
136. Patel KP, Singh R, Roubbort MJ, Kanagal-Shamanna R, Yin CC, Lu X, Pierce S, Jain N, Keating M, Kantarjian H, Medeiros LJ, Luthra R, Wierda W. Routine clinical testing for actional mutations in CLL using EndCLL Assay V1: The initial MD Anderson Experience, 2016. e-Pub 2016.
137. Quesada AE, Desai P, Tang G, Westin J, Lin P, Seegmiller A, Yin CC, Wang W, Xu J, Miranda RN, Reddy N, Medeiros LJ, Li S. MYC copy number aberrancies predict a worse prognosis in patients with diffuse large B-cell lymphoma, 2016. e-Pub 2016.
138. Yin CC, Li S, Hu S, Zuo Z, Lin P, Konoplev S, Khoury JD, Young KH, Medeiros LJ, Li Y. CD5-positive follicular lymphoma with large cell transformation, 2016. e-Pub 2016.
139. Yin CC. Molecular monitoring of chronic myelogenous leukemia, 2016. e-Pub 2016.
140. Short NJ, Jabbour E, Sasaki K, Ko H, Ravandi F, Yin CC, Khouri MR, Cortes JE, Garris R, O'Brien S, Patel K, Garcia-Manero G, Thomas D, Daver N, Naqvi K, Bose P, Jain N, Konopleva M, Kantarjian H. Additional chromosomal abnormalities in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with tyrosine kinase inhibitors: differential outcomes according to type of chromosomal abnormality, 2016. e-Pub 2016.
141. Yin CC, Ketterling RP, Medeiros LJ, Abruzzo LV. Chronic lymphocytic leukemia/small lymphocytic lymphoma with isolated t(2;14)(p13;q32), 2016. e-Pub 2016.
142. Lin P, Bueso-Ramos C, Yin CC, Miranda R, Hu Z. Histiocytic/monocytic sarcoma, 2016. e-Pub 2016.
143. Yin CC. Clinical application of molecular testing in myeloid leukemia, 2016. e-Pub 2016.
144. Loghavi S, Routbort MJ, Kanagal-Shamanna R, Wang SA, Khoury J, Ok CY, Yin CC, Singh RR, Zuo Z, Bueso-Ramos CE, Medeiros LJ, Luthra R, Patel KP. Myeloid neoplasms with recurrent GNAS mutations, 2016. e-Pub 2016.
145. Veletic I, Manshouri T, Prijic S, Yin CC, Bove IV JE, Zhang Y, Verstovsek S, Estrov Z. Multiplex quantitative imaging analysis of bone-remodeling cells in patients with myelofibrosis, 2016. e-Pub 2016.
146. Pina Oviedo S, Medeiros LJ, Li S, Alayed K, Yin CC. Langerhans cell histiocytosis in patients with concurrent lymphoma, 2016. e-Pub 2016.
147. Saksena A, Desai P, Zuo Z, Xu J, Lin P, Seegmiller A, Yin CC, Thang G, Miranda RN, Jorgensen JL, Reddy N, Medeiros LJ, Li S. MYC/BCL2 Double Hit Lymphoma: What Really Matters, 2015. e-Pub 2015.
148. Li Y, Hu S, Zuo Z, Hong M, Lin P, Li S, Konoplev S, Wang Z, Khoury J, Young K, Medeiros LJ, Yin CC. CD5-positive follicular lymphoma: clinicopathologic correlation and outcome in 88 patients. Mod Pathol 28(Supple 2):359A, 2015. e-Pub 2015.
149. Loghavi S, Al-Ibraheemi A, Zuo Z, Wang S, Garcia-Manero G, Kantarjian H, Yin CC, Miranda R, Medeiros CC, Bueso-Ramos C, Khoury J. De novo myelodysplastic syndromes with fibrosis exhibit an increased frequency of TP53 mutations and overexpression. Mod Pathol 28(Supple 2):361A, 2015. e-Pub 2015.
150. Rich A, Al D, Wang W, You MJ, Yin CC, Bueso-Ramos C, Medeiros LJ, Hu S. Pediatric chronic myelogenous leukemia in tyrosine kinase inhibitor era. Mod Pathol 28(Supple 2):373A, 2015. e-Pub 2015.
151. Shen Q, Li S, Chen M, Song J, Lu G, Tang G, Hu S, Wang X, Lin P, Medeiros LJ, Yin CC. Acute myeloid leukemia/myelodysplastic syndrome with t(3;5): clinicopathologic, immunophenotypic, and molecular genetic features of 16 cases. Mod Pathol 28(Supple 2):377A, 2015. e-Pub 2015.
152. Hodjat P, Ghosh K, Priyanka P, Thakral B, Patel K, Routbort M, Kanagal-Shamanna K, Yin CC, Luthra R, Muzzafar T. Mutation analysis in 276 cases of newly diagnosed acute myeloid leukemia by next generation sequencing: association with established prognostic variables, 2015. e-Pub 2015.
153. Issa GC, Kantarjian HM, Yin CC, Sasaki K, Garcia-Manero G, DiNardo C, Takahashi K, Ravandi F, Cortes JE, Daver N, Kadia T, Verstovsek S, Pierce S, Jabbour E. Prognostic implications of pre-treatment hypodiploidy and complex cytogenetics in adult patients with acute lymphocytic leukemia (ALL) treated with Hyper-CVAD, 2015. e-Pub 2015.
154. Ghosh K, Hodjat P, Priyanka P, Thakral B, Patel K, Routbort M, Kanagal-Shamana K, Yin CC, Zuo Z, Luthra R, Muzzafar T. Mutation analysis in 200 cases of newly diagnosed myelodysplastic syndrome by next generation sequencing: association with established prognostic variables, 2015. e-Pub 2015.
155. Aye LL, DO Loghavi S, Young KH, Medeiros J, Yin CC, Routbort M, Liang M, Hudnall D, Bueso-Ramos C, Brynes R. Pre-leukemic phase Of chronic myelogenous leukemia: morphologic and immunophenotypic characterization of 5 cases, 2015. e-Pub 2015.
156. Aung FM, Lichtiger B, Rondon G, Yin CC, Alousi A, Ahmed S, Andersson B, Bashir Q, Ciurea S, Hosing C, Jones R, Kebriaei P, Khouri I, Nieto Y, Betul O, Parmar S, Qazibash M, Shah N, Sphall E, Champlin RE, Popat UR. Pure red cell aplasia in major mismatched allogeneic hematopoietic stem cell transplantation is associated with severe pancytopenia, 2015. e-Pub 2015.
157. Wang XJ, Medeiros LJ, Thompson MA, Lin P, Yin CC, Abel TW, Li S. MYC/BCL2 double-hit (DHL) and MYC aberrations correlate with a worse outcome within MYC/BCL2 protein double-positive (DPL) high-grade B-cell lymphoma. Mod Pathol 27(Supple 2):384A, 2014. e-Pub 2014.
158. Tang G, Wang SA, Wang XI, Yin CC, Lu V, Lu G. Silent clonal cytogenetic abnormalities arising in patients treated for lymphoid neoplasms. Mod Pathol 27(Supple 2):381A, 2014. e-Pub 2014.
159. Wang XI, Bai B, Lu G, Hu S, Yin CC. t(1;3)(p36;p21) as the sole clonal abnormality in refractory acute myeloid leukemia:320, 2013. e-Pub 2013.
160. Hu S, Young K, Medeiros LJ, Yin CC. T-lymphoblastic lymphoma with eosinophilia and t(8;13)(p11.2;q12):317, 2013. e-Pub 2013.
161. Wang XI, Patel K, Lin P, Zuo Z, Bueso-Ramos CE, Luthra R, Medeiros LJ, Yin CC. Clinicopathologic and molecular genetic features of de novo myeloid sarcoma. Mod Pathol 26(suppl 2):365A, 2013. e-Pub 2013.
162. Dinardo CD, Daver N, Jain N, Pemmaraju N, Bueso-Ramos CE, Yin CC, Pierce S, Jabbour E, Quintas-Cardama A, Cortes J, Kantarjian H, Garcia-Manero G, Verstovsek S. Myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN, U): Natural history and clinical outcome by therapeutic approach, 2013. e-Pub 2013.
163. Lu G, Schulz RA, Bueso-Ramos CE, Cortes JE, Wang HI, Medeiros LJ, Yin CC. Acute myeloid leukemia with double-hit genetic abnormalities of the FLT3 gene:360, 2013. e-Pub 2013.
164. Kanagal-Shammanna R, Bueso-Ramos CE, Medeiros LJ, Yin CC. Acute myeloid leukemia with isolated i(17q) and MDM4 mutation, 2013. e-Pub 2013.
165. Hoehn D, Lu G, Konoplev S, Bueso-Ramos CE, Zuo Z, Medeiros LJ, Yin CC. t(15;17)(q24.1;q21.2)/PML-RARA in blast phase of chronic myelogenous leukemia: a rare form of clonal evolution, 2013. e-Pub 2013.
166. Zuo Z, Bueso-Ramos CE, Yin CC, Medeiros LJ. Acute myeloid leukemia with monocytic differentiation:186, 2013. e-Pub 2013.
167. Jaso JM, Lu VW, Yin CC, Zhao M, Abruzzo L, You MJ, Medeiros LJ, Lu G. B-lymphoblastic leukemia with t(14;19)(q32;p13.1) involves IGH@ and EPOR genes and is associated with an aggressive clinical course. Mod Pathol 26(suppl 2):335A, 2013. e-Pub 2013.
168. Alayed K, Patel K, Zuo Z, Verma S, Galbincea J, Cason RC, Luthra R, Medeiros LJ, Yin CC. BRAF mutation occurs more frequently in pulmonary Langerhans cell histiocytosis and in younger patients 15(6):858-859, 2013. e-Pub 2013.
169. Yabe M, Bai B, Wang XI, Zuo Z, Yin CC. Novel Chromosomal Aberration, t(2;16)(p21;p11.2),t(11;14)(p13;p11.2), as evidence of clonal evolution in a case of relapsed acute myeloid leukemia:318, 2013. e-Pub 2013.
170. Lu G, Yin CC, Abruzzo LV, Luthra R, Abraham R, Kanagal-Shammanna R, Medeiros LJ. Acquired silent cytogenetic clones arising in patients treated successfully for lymphoma. Mod Pathol 26(suppl 2):343A, 2013. e-Pub 2013.
171. Wang XI, Routbort M, Patel K, Bueso-Ramos CE, Yin CC. Acute myeloid leukemia arising from myelodysplastic syndrome, diploid karyotype, with mutations in FLT3, NPM1, DNMT3A and TP53:355, 2013. e-Pub 2013.
172. Wang XI, Patel K, Routbort M, Zuo Z, Lin P, Bueso-Ramos CE, Luthra R, Medeiros LJ, Yin CC. De novo myeloid sarcoma with subsequent AML development, diploid karyotype and mutations in IDH2, TP53 and GNAS:357, 2013. e-Pub 2013.
173. Zhou Y, Routbort M, Young KH, Wang S, Hoehn D, Tang G, Bueso-Ramos C, Yin CC, Miranda RN, Medeiros LJ, Lin P. Negative TdT expression predicts adverse treatment outcome in T-lymphoblastic leukemia/lymphoma in adults. Mod Pathol 25(suppl 2):386A, 2012. e-Pub 2012.
174. Jaso J, Yin CC, Jabcuga CE, Medeiros LJ, Chen L. CD5-positive nodal marginal zone lymphoma: A clinicopathologic study of 7 cases. Mod Pathol 25(suppl 2):344A, 2012. e-Pub 2012.
175. Kanagal-Shamanna R, Yin CC, Muddasani R, Luthra R, Cortes J, Zuo Z, Chen SS, Hu S, Abruzzo LV, Miranda RN, Medeiros LJ, Lu G. Acute myeloid leukemias with translocations involving 4q12/PDGFRA: Frequent involvement of ETV6. Mod Pathol 25(suppl 2):346A, 2012. e-Pub 2012.
176. Warren M, Luthra R, Yin CC, Ravandi F, Medeiros LJ, Zuo Z. Clinical impact of change of FLT3 mutation status in acute myeloid leukemia patients. Mod Pathol 25(suppl 2):379A, 2012. e-Pub 2012.
177. Yin CC, Hu S, Medeiros LJ, Lu G. Isolated clonal trisomy 13 in Philadelphia chromosome-negative metaphases in patients with chronic myelogenous leukemia. Mod Pathol 25(suppl 2):383A, 2012. e-Pub 2012.
178. Chen SS, Yin CC, Konoplev SN, Young KH, Muddasani R, Medeiros LJ, Lu G. Acquired trisomy 21 as a sole chromosomal abnormality is associated with a heterogeneous group of myeloid neoplasms and variable disease outcome. Mod Pathol 25(suppl 2):329A, 2012. e-Pub 2012.
179. Ng D, Liang S, Tian T, Yin CC, Young KH, Jorgensen J, Hoehn D, Sargent R, Miranda R, Amin H, You J, Schlette E, Lin P. Assessing minimal disease in plasma cell neoplasms: A comparison between multicolor flow cytometry and immunohistochemistry. Mod Pathol 25(suppl 2):357A, 2012. e-Pub 2012.
180. Li S, Yin CC, Medeiros LJ, Lu G, Lin P. Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26;q22) are commonly therapy related diseases associated with poor outcome. Mod Pathol 25(suppl 2):351A, 2012. e-Pub 2012.
181. Jabbour EJ, Kantarjian HM, Yin CC, Ravandi F, Cortes JE, Garcia-Manero G, Ghanem H, Kadia TM, Faderl S, O'Brien S, Mathisen MS, Brandt M, Pemmaraju N, Thomas DA, Bass J, Borthakur G. Dynamics of molecular response in patients with acute myeloid leukemia with core binding factor abnormalities treated with high-dose cytarabine regimen, 2012. e-Pub 2012.
182. Lee HC, Yin CC, Qazilbash MH, Wang XI, Lu V, Lu G. Acquired therapy-related cytogenetic clones in patients treated for multiple myeloma, 2012. e-Pub 2012.
183. Hoehn D, Zhou Y, Bueso-Ramos CE, Lun G, Zuo Z, Konoplev S, Hsu B, Medeiros LJ, Yin CC. t(15;17)(q22;q21)/PML-RARA in blast phase of chronic myelogenous leukemia: a unique clonal evolution, 2011. e-Pub 2011.
184. Li S, Zuo Z, Bueso-Ramos CE, Yin CC. FLT3 mutation in a case of T-lymphoblastic leukemia with aberrant CD117 expression, 2011. e-Pub 2011.
185. Bai B, Harper E, Cheong SH, Lovshe D, Yang S, Yin CC. New clonal chromosome aberrations in a case of relapsed acute myeloid leukemia, 2011. e-Pub 2011.
186. George AM, Zuo Z, Hu P, Yin CC. Impact of numbers of FLT3 internal tandem duplication on clinicla outcome of patients with acute myeloid leukemia and diploid karyotype, 2011. e-Pub 2011.
187. Barkoh B, Do D, Hai S, Patel K, Yin CC, Medeiros LJ, Luthra R. High resolution melting analysis as an upfront cost effective screening method for the detection of low frequency KIT exon 17 mutations in acute myeloid leukemia in clinical laboratory 13(6):732, 2011. e-Pub 2011.
188. Jasso J, Chen L, Lin P, Li S, Miranda RN, Medeiros LJ, Yin CC. CD5-positive MALT lymphoma: a clinicopathologic study of 9 cases 24 (suppl 1):302A, 2011. e-Pub 2011.
189. Yin CC, Lu G, Medeiros LJ, Feng X, Keating MJ, Abruzzo LV. Del(20q) in patients with chronic lymphocytic leukemia is associated with prior chemotherapy, atypical morphology, ZAP70 expression and unmutated IGVH genes 24 (suppl 1):331A, 2011. e-Pub 2011.
190. Shamanna RK, Miranda R, Yin CC, Bueso-Ramos C, Muddasani R, Medeiros LJ, Lu G. Isolated deletion of chromosome 20q in de novo myelodysplastic syndrome is associated with favorable prognosis and wild type FLT3 or RAS 24 (suppl 1):304A, 2011. e-Pub 2011.
191. Chen SS, Zuo Z, Luthra R, Lu G, Borthakur G, Wang S, Medeiros LJ, Yin CC. Double mutations of NRAS and KRAS in acute myeloid leukemia and myelodysplastic syndrome are associated with monocytic differentiation, multilineage dysplasia, increased myeloblasts and prior chemotherapy 24 (suppl 1):290A, 2011. e-Pub 2011.
192. Konoplev SK, Yin CC, Kornblau SM, Kantrajian HM, Konopleva M, Andreeff M, Lu G, Zuo Z, Luthra R, Medeiros LJ, Bueso-Ramos CE. NPM1 mutation occurs in a subset of Ph+ AML suggesting that this entity is distinct from CML in myeloid blast phase 13(6):731, 2011. e-Pub 2011.
193. Ma D, Luthra R, Chen SS, Yin CC, Sargent RL, Patel KP, Medeiros LJ, Zuo Z. RAS mutation analysis in 9334 solid and hematopoietic malignancies 24 (suppl 1):394A, 2011. e-Pub 2011.
194. Li S, Feng X, Lin P, Konoplev S, Medeiros LJ, Yin CC. Extranodal NK/T-cell lymphoma, nasal type, a retrospective study of 50 cases from the United States 24 (suppl 1):307A, 2011. e-Pub 2011.
195. Li S, Medeiros LJ, Fayad L, Lennon P, Yin CC, Lin P. "Double hit" high-grade B-Cell lymphomas: an aggressive disease with heterogeneous histologic features and clinical outcome 24 (suppl 1):306A, 2011. e-Pub 2011.
196. Zuo Z, Greaves WO, Luthra R, Sargent R, Chen SS, Galbincea J, Medeiros LJ, Yin CC. KIT mutation is rare in acute myeloid leukemias, almost always involves exon 17, and occurs predominantly in AML with t(8;21)(q22;q22) 13(6):729, 2011. e-Pub 2011.
197. Shamanna RK, Yin CC, Lu G, Medeiros LJ, Nguyen M, Hoehn D, Garcia-Manero G, Vadhan-Raj S, Bueso-Ramos C. Myelodysplastic/myeloproliferative neoplasm with isolated isochromosome 17q: an aggressive clinical syndrome with prominent multilineage dysplasia, increased blasts and wild type NPM1 24 (suppl 1):304A, 2011. e-Pub 2011.
198. Yang Y, Gao X, Han X, Huang X, Liu Q, Zhang YH, Yin, CC, Chen L, You MJ. Inactivation of INK4a/ARF accelerates the development of PTEN deficient T-ALL 116(21):1706, 2010. e-Pub 2010.
199. Jabbour E, Kantarjian HM, Jones D, Yin, CC, Burton E, cortes J. Characteristics and outcome of patients with V299L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors 116(21):1404, 2010. e-Pub 2010.
200. Han JY, Mulligan S, Hu P, Lennon A, Yin, CC, Lin P. MiRNA-150 and MiRNA-155 expression patterns are distinct in acute myeloid leukemia versus blast phase of chronic myelogenous leukemia associated with inv(3)(q21q26), 2010. e-Pub 2010.
201. Qiu X, Sun X, He Z, Lin P, You MJ, Chen L, Dai CW, Yin, CC. Expression of immunoglobulin gene in myeloblasts from patients with acute myelogenous leukemia and its distinct V K J K recombination pattern. Cancer Res 70(8(supplement)):2745-2745, 2010. e-Pub 2010.
202. Sun J, Chen S, Cui W, Yin, CC, Medeiros LJ, Lu G. Chromosome 20q deletion - a recurrent cytogenetic abnormality in chronic myelogeneous leukemia patients in remission, 2010. e-Pub 2010.
203. Dai A, Zhao C, Yin CC, Chen L, Sun X, Dave S, Huang X, Zhang YH, Han X, You MJ. Hypermethylation of DBCCR1 gene in acute myeloid leukemia. Proceedings of the 101th Annual Meeting of the American Association for Cancer Research, 2010. e-Pub 2010.
204. Gurevich I, Zhao C, Yin, CC, Han X, Lin P, Gao X, Nguyen MH, Pan E, Medeiros LJ, Bueso-Ramos C, You MJ. Aberrant nuclear and loss of PTEN expression in acute myeloid leukemia, 2010. e-Pub 2010.
205. He Z, Yin, CC. Bacteria could promote proliferation of AML cells. Proceedings of the 101th Annual Meeting of the American Association for Cancer Research, 2010. e-Pub 2010.
206. Zhao C, Dai A, Chen L, Sun X, Han X, Yin, CC, You MJ. Epigenetic Inactivation of DBC1 in Acute Myeloid Leukaemia 114:4429, 2009. e-Pub 2009.
207. Littlejohn M, Lennon A, Hu P, Im W, Pepper R, Lin P, Medeiros LJ, Yin, CC. FISH analysis of BCL-2 and BCL-6 rearrangements in germinal center and non-germinal center types of diffuse large B-cell lymphoma in China, 2009. e-Pub 2009.
208. Im W, Yin, CC, Littlejohn M, Hu P, Lin P, Medeiros LJ, Lennon A. MYC rearrangements in diffuse large B-cell lymphoma cases from China, 2009. e-Pub 2009.
209. Yin, CC, Medeiros LJ, Lin P. Marginal zone B-cell lymphoma with marked plasmacytic differentiation, 2009. e-Pub 2009.
210. Im W, Yin, CC, Littlejohn M, Hu P, Lin P, Medeiros LJ, Lennon A. MYC rearrangements in diffuse large B-cell lymphoma cases from China, 2009. e-Pub 2009.
211. Littlejohn M, Lennon A, Hu P, Im W, Pepper R, Lin P, Medeiros LJ, Yin, CC. FISH analysis of BCL-2 and BCL-6 rearrangements in germinal center and non-germinal center types of diffuse large B-cell lymphoma in China, 2009. e-Pub 2009.
212. Im W, Yin, CC, Littlejohn M, Hu P, Lin P, Medeiros LJ, Lennon A. MYC rearrangements in diffuse large B-cell lymphoma cases from China, 2009. e-Pub 2009.
213. Qiu X, Zheng J, Huang J, Mao Y, Zhu X, Yin, CC. Immunoglobulin gene transcripts from human epithelial cancer cells have distinct VHDJH or VKJK recombination. Proceedings of the 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, 2009. e-Pub 2009.
214. Qiu X, Lin P, Sun X, You MJ, Medeiros LJ, Yin, CC. Detection of mono/oligo clonal IgH gene rearrangements and characterization of associated clinicopathologic features in acute myeloid leukemia 22:281, 2009. e-Pub 2009.
215. Littlejohn M, Lennon A, Hu P, Im W, Pepper R, Lin P, Medeiros LJ, Yin, CC. FISH analysis of BCL-2 and BCL-6 rearrangements in germinal center and non-germinal center types of diffuse large B-cell lymphoma in China, 2009. e-Pub 2009.
216. Mallampati S, Sun B, Gong Y, Wang E, You MJ, Amin HM, Ma Y, Shen H, Zweidler-McKay P, Jones D, Yin CC, Glassman A, Kantarjian HM, Issa JP, Arlinghaus RB, Sun X. Rooting into the soil, a model for the role of Sox4 in leukemia 112:3794, 2008. e-Pub 2008.
217. Liu Q, Gao X, Yin CC, Ling C, You MJ. Resveratrol inhibits proliferation and induces apoptosis of mouse Pten null T-cell acute lymphocytic leukemia cells 112:3967, 2008. e-Pub 2008.
218. Lu, G, Yin, CC, Medeiros, LJ, Abruzzo, LV. Del (15q) is a recurrent cytogenetic "minor route" abnormality in evolving CML, 2008. e-Pub 2008.
219. Li T, Medeiros LJ, Lin P, Yin H, Guo H, Yin, CC. Immunohistochemical profile of diffuse large B-Cell lymphoma in China 21 (suppl 1s):261A, 2008. e-Pub 2008.
220. Konoplev S, Nguyen M, Huang X, Rassidakis GZ, Garcia-Manero G, Yin CC, Amin H, Schlette E, Lin P, Vega-Vazquez F, Admirand J, Huh Y, You J, Jorgensen JL, Kantarjian HM, Medeiros LJ, Bueso-Ramos C. Cytoplasmic expression of nucleophosmin does not predict favorable prognosis in AML patients 21 (suppl 1s):260A, 2008. e-Pub 2008.
221. You MJ, Ku PT, Yin, CC, Bargmann W, Wong KK, Medeiros LJ, Bose HR, Dorfman DM. Expression of Golgin-84 in non-Hodgkin lymphomas and plasma cell myelomas 21 (suppl 1s):282A, 2008. e-Pub 2008.
222. Jones D, Yin CC. Chronic myeloid leukemia in blast transformation with shifts in genetically related but distinct CML clones following sequential introduction of effective bcr-abl kinase inhibitors, 2007. e-Pub 2007.
223. Yin CC, Medeiros LJ, Barron LL, Abruzzo LV. Chronic lymphocytic leukemia/small lymphocytic lymphoma with t(2;14)(p13;q32) is often associated with atypical morphologic features, unmutated IgVH genes and aggressive clinical course 20 (suppl 2s):265A, 2007. e-Pub 2007.
224. Zhang C, Li B, Talpur R, Yin CC, Duvic M. Biomarkers of vorinostat resistance in cutaneous T cell lymphoma 110:1381, 2007. e-Pub 2007.
225. Chen L, Guo J, Jones D, Luthra R, Yin CC, Lin P. Clinical implications of quantitative and qualitative post-treatment detection of AML1-ETO in AML, 2006. e-Pub 2006.
226. Yin CC, Medeiros LJ, Lin P, Cromwell C, Mehta A, Jones D, Luthra R, Abruzzo LV. Sequence analysis proves clonal identity in five patients with typical and blastoid mantle cell lymphoma 19 (suppl 1s):253A, 2006. e-Pub 2006.
227. Yin CC, Luthra R, Galbincea J, Cortes J, Jones D. A Pyrosequencing method for quantitation of mutated bcr-abl transcripts in chronic myelogenous leukemia patients with imatinib resistance 18 (suppl 1s):258A, 2005. e-Pub 2005.
228. Yin CC, Glassman AB, Lin P, Valbuena JR, Jones D, Luthra R, Medeiros LJ. Morphologic, cytogenetic and molecular abnormalities in therapy-related acute promyelocytic leukemia 18 suppl 1s:258A, 2005. e-Pub 2005.
229. Merzianu M, Yin CC, Lin P, Glassman AB, Medeiros LJ, Huh Y. inv(16)(p13q22) in blast phase of chronic myelogenous leukemia – Clinical, morphologic, cytogenetic and molecular study of 5 cases, 2005. e-Pub 2005.
230. Yin CC, Cortes J, Luthra R, Barkoh B, Giles F, Kantarjian H, Jones D. Tandem DNA and RNA quantitative sequencing analysis reveals differential effects of changes in therapy on mutated and unmutated bcr-abl in chronic myelogenous leukemia, 2005. e-Pub 2005.
231. Valbuena JR, Rassidakis GZ, Estey E, Luthra R, Yin CC, Medeiros LJ, Jones D. Ras mutations are associated with monocytic differentiation in myeloid leukemias and are an adverse prognostic factor in chronic myelomonocytic leukemia (CMML) 18 (suppl 1s):255A, 2005. e-Pub 2005.
232. Yin CC, Cortes J, Glassman AB, Valbuena JR, Hayes K, Kantarjian H, Jones D. AML1-MDS1-EVI1 activation through t(3;21)(q26; q22): An aggressive syndrome of myeloid blast transformation following antimetabolite therapy 18 (suppl 1s):259A, 2005. e-Pub 2005.
233. Vega CA, Luthra R, Yin CC, Verstovsek S, Kantarjian H, Jones D. Quantitative detection of the V617F mutation in JAK2 and its role in the diagnosis of chronic myeloproliferative disorders 7:666, 2005. e-Pub 2005.
234. Yin CC, Rassidakis GZ, Medeiros LJ, Bueso-Ramos C, Abruzzo LV, Handy B, Lin P. Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein – A clinicopathological study of 26 cases 17 (suppl):277A, 2004. e-Pub 2004.
235. Yin CC, Luthra R, Cortes J, Reeves N, Hayes K, Glassman A, Kantarjian H, Jones D. Imatinib resistance in chronic myelogenous leukemia is frequently associated with either ABL kinase mutations or with secondary rearrangements of the BCR-ABL locus 6:416, 2004. e-Pub 2004.
236. Li Y, Boyert L, Lacy M, Yin C, Horvat RT. Assessments of antimicrobial susceptibility tests and PCR-assay for detection of macrolide-resistance Streptococcus pneumoniae, 2001. e-Pub 2001.
237. Djavani M, Yin C, Lukashevich IS, Salvato MS. Cross-protective immunity to LCMV in mice inoculated with Lassa virus nucleoprotein, 2000. e-Pub 2000.
238. Yin C, Rakasz E, Evans PS, Ruckwardt T, Waterman PM, Enders PJ, Poccia T, Martini F, Malkovsky M, Pauza CD. Changes in the gamma delta T cell repertoire after HIV-1 infection, 1999. e-Pub 1999.
239. Evans PS, Yin C, Ruckwardt T, Pauza CD. How did you know that? Antigen recognition by gamma delta T cells, 1999. e-Pub 1999.
240. Yin C, Schmidt DS, Pauza CD, Hideo Y, Salvato MS. High FasL predisposes rhesus macaques to rapid AIDS progression, 1999. e-Pub 1999.
241. Yin C, Dykhuizhen M, Mitchen JL, Pauza CD, Salvato MS. Role of MHC-unrestricted cytotoxicity in AIDS pathogenesis, 1998. e-Pub 1998.
242. Yin C, Wu MS, Dykhuizen M, Mitchen JL, Pauza CD, Salvato MS. Expression of SIV envelope activates Fas and sensitizes cells to Fas-mediated apoptosis, 1998. e-Pub 1998.
243. Schenkel AR, Yin C, Hinds PW, Trivedi P, Salvato MS, Pauza CD. Pertussis toxin treatment increases survival of SIV infected rhesus macaques, 1997. e-Pub 1997.
244. Djavani M, Yin C, Xia L, Lukashevich I, Salvato MS. Mucosal and systemic immune responses following oral immunization with live recombinant salmonella expressing Lassa fever virus nucleoprotein, 1997. e-Pub 1997.
245. Yin C, Wu MS, Johnson EG, Pauza CD, Salvato MS. Role of MHC-unrestricted cytotoxicity in AIDS pathogenesis, 1997. e-Pub 1997.
246. Schenkel AR, Yin C, Pauza CD. Inhibition of pertussis toxin on SIV infection, 1996. e-Pub 1996.
247. Yin C, Salvato MS. Effect of pertussis toxin on LCMV infection in mice, 1995. e-Pub 1995.
248. Zhang BX, Yin C. Functional and phenotypic study of tumor-infiltrating lymphocytes cultured in vitro, 1990. e-Pub 1990.
249. Zhang BX, Yin C. The inhibitory effect of human LAK cells on tumorigenicity of autologous cancers in nude mice. Proceedings of the Third National Symposium of Experiment and Research of Immunodeficient Animals. Shanghai, China, 1990. e-Pub 1990.

Book Chapters

1. Wu L, Xia M, Yin CC. Expression, function and significance of non-B-cell-derived immunoglobulin in hematologic system. In: Non-B cell Derived Immunoglobulins - the structure, characteristics and the implication on clinical medicine, 2024.
2. Zuo Z, Yin CC. Blood Cancer. In: Clinical Molecular Diagnostics. Springer, 2022.
3. Zuo, Z, Yin, CC, Zhang, L, Wang, L, Ren, Z. Blood Disorders. In: Clinical Molecular Diagnostics, 641-664, 2021.
4. Li S, Yin CC. Myelodysplastic Syndrome. In: Precision Molecular Pathology of Myeloid Neoplasms. Springer, 2017.
5. Auerbach A, Yin CC. Follicular Lymphoma. In: Diagnostic Pathology: Molecular Oncology. Amirsys/Elsevier, 6-34, 2015.
6. Yin CC. Follicular Lymphoma. In: Nose V. Diagnostic Pathology: Familial Cancer Syndromes. Amirsys, II-2:14-23, 2014.
7. Yin CC. Reactive Follicular Hyperplasia. In: Putman A, Thompson K. Non-neoplastic Pediatric Pathology. Amirsys, 11:2-7, 2014.
8. Yin CC. Kimura Disease. In: Putman A, Thompson K. Non-neoplastic Pediatric Pathology. Amirsys, 11:34-41, 2014.
9. Yin CC. Reactive Paracortical Hyperplasia. In: Putman A, Thompson K. Non-neoplastic Pediatric Pathology. Amirsys, 11:8-15, 2014.
10. Yin CC. Mantle Cell Lymphoma. In: Nose V. Diagnostic Pathology: Familial Cancer Syndromes. Amirsys, II-2:36-39, 2014.
11. Yin CC. Chronic Granulomatous Lymphadenitis. In: Putman A, Thompson K. Non-neoplastic Pediatric Pathology. Amirsys, 11:68-75, 2014.
12. Yin CC, Jones D. Molecular Diagnostics of Myeloid Neoplasms. In: Cheng L, Zhang D. Essentials of Molecular Genetic Pathology, 2nd Edition. Springer, 865-886, 2013.
13. Yin CC. Detection and Monitoring of Minimal Residual Disease in Myeloid Neoplasms. In: Tan D, Lynch H. Principles of Molecular Diagnostics and Personalized Cancer Medicine. Lippincott Williams & Wilkins, 247-264, 2013.
14. Yin CC. Nodular Sclerosis Hodgkin Lymphoma. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 4;22-31, 2011.
15. Yin CC. Suppurative Lymphadenitis. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 2;10-13, 2011.
16. Yin CC. Nodal Follicular Lymphoma. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 6;30-41, 2011.
17. Yin CC. Primary Cutaneous Anaplastic Large Cell Lymphoma. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 10;60-65, 2011.
18. Yin CC. Mantle Cell Lymphoma, Blastoid Variant. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 6;46-51, 2011.
19. Yin CC. Post-Transplant Lymphoproliferative Disorder: Early Lesions and Polymorphic. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 11;28-33, 2011.
20. Yin CC. Mixed Cellularity Hodgkin Lymphoma. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 4;32-37, 2011.
21. Yin CC. Lymphocyte-Depleted Hodgkin Lymphoma. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 4;38-39, 2011.
22. Yin CC. Mantle Cell Lymphoma. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 6;42-45, 2011.
23. Yin CC. Chronic Granulomatous Lymphadenitis. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 2;2-9, 2011.
24. Yin CC. Reactive Follicular Hyperplasia. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 1;2-7, 2011.
25. Yin CC. Lymphomatoid Papulosis. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 10;66-71, 2011.
26. Yin CC. Kimura Disease. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 3;30-37, 2011.
27. Yin CC. Reactive Paracortical Hyperplasia. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 1;8-15, 2011.
28. Yin CC, Jones D. Myeloproliferative Neoplasms. In: Jones D. Neoplastic Hematopathology: Experimental and Clinical Approaches. Humana Press Inc, 177-192, 2010.
29. Yin CC, Jones D. Molecular Diagnostics in Myeloid Leukemias. In: Cheng L, Zhang D. Essentials of Molecular Genetic Pathology. Humana Press Inc, 675-688, 2007.
30. Yin CC. Blood Cancer 2nd edition. In: Clinical Molecular Diagnostics 2nd edition. Springer.

Letters to the Editor

1. Hu Z, Yin CC, Sun X, Han X, Wang W, Wang S, You MJ. A diagnostic dilemma for a patient with skin lesions and marked leukocytosis: mixed-phenotype acute leukaemia or blastic plasmacytoid dendritic cell neoplasm with aberrant cytoplasmic CD3 expression?. Pathology 57: 371-374, 2025.
2. Kim DH, Wang SA, Wang W, Tang G, Li S, Yin CC, Lin P, Konopleva M, You MJ, Miranda RN, Wang X, Wei Q, Medeiros LJ, Xu J. Acute myeloid leukemia with mast cell differentiation is characterized by interstitial mast cells, complex karyotype, TP53 alterations and poor prognosis. Haematologica 109: 2711-2715, 2024.
3. Sheikh IN, AlQahtani S, Yin CC, McCall D, Cuglievan B, Ragoonanan D, Connors JS, Gibson A, Nunez C, Roth M, Ohanian M, Borthakur G, Garcia MB. KIT-mutated pediatric core-binding factor systemic mastocytosis-acute myeloid leukemia treated with avapritinib and decitabine. Pediatr Blood Cancer 71: e30898, 2024.
4. Alotaibi AS, Abdulrazzaq M, Patel KP, Ravandi F, Konoplev S, Bueso-Ramos C, Yin CC, Muzzafar T, Tang G, Futreal A, Jain N, Konopleva MY, Pemmaraju N. Acute promyelocytic leukemia (APL) with an IRF2BP2-RARA fusion transcript: an aggressive APL variant. Leuk Lymphoma 61: 3018-3020, 2020.
5. Jain P, Wang SA, Yin CC, Abaza Y, Verstovsek S, Estrov Z. A case of lymphocytic variant hypereosinophilic syndrome with sub-diagnostic systemic mastocytosis. Blood Res 52: 71-73, 2017.